Share
Explore
Opps
Opportunities
Row
Owner Role
Opportunity Owner
Sales Manager
Account Name
Opportunity Name
Stage
Fiscal Period
Amount Currency
Amount
Expected Revenue Currency
Expected Revenue
Probability
Age
Close Date
Created Date
Next Step
Lead Source
Type
Account I D18 Digit
Ultimate Account ID
Ultimate Account ID 1
Ultimate Parent ID
Product
Product2
Product Line
Account ID
Parent Account ID
Low Usage
1
4/4/2022
US Sales User - R&D SMB
Seth Fox
David Florez
Coherus BioSciences, Inc.
Renewal 2022: Coherus Biosciences - eTMF - 10 Active / 11 Archive Sites
Closed Won
Q1-2023
100
339
4/4/2022
5/1/2021
Renewal
0015000000tq1wMAAQ
0015000000tq1wMAAQ
eTMF
Vault
R&D
0015000000tq1wM
Coherus Biosciences, Inc.
2
4/5/2022
US Sales User - R&D SMB
Chloe Kearns
Jim Thai
Nektar Therapeutics
Renewal 2022: Nektar - Vault Subs/Subs A - 20 Full, 14 Archive
Closed Won
Q1-2023
100
356
4/5/2022
4/15/2021
Renewal
0015000000Lq8D5AAJ
0012J00002PUIc1QAH
0012J00002PUIc1QAH
0012J00002PUIc1QAH
Submissions
Vault
R&D
0015000000Lq8D5
0012J00002PUIc1
Nektar Therapeutics
3
4/5/2022
US Sales User - CRO
Greyson McGrail
Katie Tipton
Pharma Start, LLC
Renewal 2022: Firma Clinical - Vault eTMF - DermaSensor - 22 Sites
Closed Won
Q1-2023
100
105
4/5/2022
12/21/2021
Subscription
0012J00002K4ubFQAR
0012J00002K4ubFQAR
R&D
0012J00002K4ubF
Firma Clinical
4
4/6/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Allucent
Renewal 2022: CATO SMS - QD VT ELA 1500
Closed Won
Q1-2023
100
364
4/6/2022
4/7/2021
Renewal
0015000000htJv3AAE
0015000000htJv3AAE
QualityDocs; Vault Training
Vault
R&D
0015000000htJv3
Pharm-Olam International, LLC
5
4/7/2022
JP Sales User - R&D ENT
Junichiro Tomoda
Sumitomo Pharma Co., Ltd.
Renewal 2022: Dainippon Sumitomo Global Submission 990 users
Closed Won
Q1-2023
100
362
4/7/2022
4/11/2021
Renewal
0015000000ORqoNAAT
0012J00002MKw1cQAD
0012J00002MKw1cQAD
0012J00002MKw1cQAD
Submissions
Vault
R&D
0015000000ORqoN
0012J00002MKw2r
SUMITOMO DAINIPPON PHARMA CO., LTD.
6
4/8/2022
US Sales User - R&D SMB
Will Gould
Jonathan Waldvogel
Checkmate Pharmaceuticals Inc.
Renewal 2022: Checkmate Pharmaceuticals_Vault eTMF
Closed Won
Q1-2023
100
329
4/8/2022
5/14/2021
Renewal
0015000001JKFZmAAP
0015000001JKFZmAAP
eTMF
Vault
R&D
0015000001JKFZm
Checkmate Pharmaceuticals, Inc.
7
4/11/2022
US Sales User - R&D SMB
Will Gould
Jonathan Waldvogel
Checkmate Pharmaceuticals Inc.
Renewal 2022: Checkmate Pharmaceuticals_Vault Quality (QDocs & Training)
Closed Won
Q1-2023
100
285
4/11/2022
7/1/2021
Renewal
0015000001JKFZmAAP
0015000001JKFZmAAP
QualityDocs; Vault Training
Vault
R&D
0015000001JKFZm
Checkmate Pharmaceuticals, Inc.
8
4/12/2022
US Sales User - R&D SMB
Alana Wirt
Adam De Oliveira
Protara Therapeutics, Inc.
Renewal 2022: Protara eTMF archive 43 sites 11 active
Closed Won
Q1-2023
100
357
4/12/2022
4/20/2021
Renewal
0012J00002N3aodQAB
0012J00002N3aodQAB
eTMF
Vault
R&D
0012J00002N3aod
Protara Therapeutics
9
4/12/2022
US Sales User - R&D SMB
Will Gould
Jonathan Waldvogel
Intarcia Therapeutics, Inc.
Renewal 2022: Intarcia Therapeutics_Veeva QualityDocs Superseding Licensing Extension April 2022
Closed Won
Q1-2023
100
71
4/12/2022
1/31/2022
Subscription
0015000001IfBXpAAN
0015000001IfBXpAAN
R&D
0015000001IfBXp
Intarcia Therapeutics, Inc.
10
4/15/2022
US Sales User - R&D SMB
Kerri Klidas
Jim Thai
Parker Institute for Cancer Immunotherapy
Renewal 2022: Parker Institute - QualityDocs_200 ELA & 33 eTMF- Safety
Closed Won
Q1-2023
100
308
4/15/2022
6/12/2021
Renewal
0015000001EbYF8AAN
0015000001EbYF8AAN
eTMF; QualityDocs
Vault
R&D
0015000001EbYF8
Parker Institute for Cancer Immunotherapy
11
4/15/2022
EU Sales User - R&D SMB
Raminta Baskyte
Ecuphar NV
Renewal 2022: Ecuphar - Ph I - QMS
Closed Won
Q1-2023
100
394
4/15/2022
3/17/2021
Sales
Subscription
00150000019EABEAA4
0015000001T4uznAAB
0015000001T4uznAAB
0015000001T4uznAAB
QMS; QualityDocs
Vault
R&D
00150000019EABE
0015000001T4uzn
Ecuphar NV
12
4/15/2022
EU Sales User - R&D SMB
Raminta Baskyte
Ecuphar NV
Renewal 2022: Ecuphar - RIM - Subs, Reg & Ramp
Closed Won
Q1-2023
100
394
4/15/2022
3/17/2021
Sales
Subscription
00150000019EABEAA4
0015000001T4uznAAB
0015000001T4uznAAB
0015000001T4uznAAB
Registrations; Submissions
Vault
R&D
00150000019EABE
0015000001T4uzn
Ecuphar NV
13
4/15/2022
US Sales User - MedTech ENT
Ryan Lapinski
Abbott MedTech
Renewal 2022: Abbott Vascular LATAM/CALA
Closed Won
Q1-2023
100
347
4/15/2022
5/3/2021
Renewal
0012J00002ZERRwQAP
0012J00002MK4X8QAL
0012J00002MK4X8QAL
0012J00002MK4X8QAL
PromoMats
Vault
R&D
0012J00002ZERRw
0012J00002MK4X8
Abbott Laboratories, Inc.
14
4/17/2022
EU Sales User - CDMS
Greet Van Thillo
Allucent
Renewal 2022: Specialized Medical Services-oncology B.V. eTMF CTMS SSU
Closed Won
Q1-2023
100
352
4/17/2022
5/1/2021
Renewal
0015000000htJv3AAE
0015000000htJv3AAE
CTMS; eTMF
Vault
R&D
0015000000htJv3
Pharm-Olam International, LLC
15
4/20/2022
US Sales User - R&D SMB
Jared Steinberg
Jonathan Waldvogel
Angion Biomedica Corp.
Renewal 2022: Angion QualityDocs
Closed Won
Q1-2023
100
355
4/20/2022
5/1/2021
Renewal
0015000001IHjoaAAD
0015000001IHjoaAAD
QualityDocs
Vault
R&D
0015000001IHjoa
Angion Biomedica Corp.
16
4/20/2022
US Sales User - CRO
Joey Sineno
Katie Tipton
St. Jude Children's Research Hospital, Inc.
Renewal 2022: St Jude CRH - RIM Suite (Subs, SubsA, Pub)
Closed Won
Q1-2023
100
345
4/20/2022
5/10/2021
Renewal
00150000014RszdAAC
00150000014RszdAAC
Submissions; Submissions Archive; Submissions Publishing
Vault
R&D
00150000014Rszd
St. Jude Children's Research Hospital
17
4/20/2022
JP Sales User - R&D ENT
Hajime Kosuge
Daiichi Sankyo Company, Limited. (Japan KK)
Renewal 2022: Daiichi Sankyo - CoMET QualityDocs - JP/US/EU
Closed Won
Q1-2023
100
294
4/20/2022
7/1/2021
Renewal
0015000000aQnvWAAS
0012J00002MK4XEQA1
0012J00002MK4XEQA1
0012J00002MK4XEQA1
QualityDocs
Vault
R&D
0015000000aQnvW
0012J00002aX68D
Daiichi Sankyo Co.,LTD
18
4/22/2022
EU Sales User - CDMS
Sam Rolfe
Exom Group Srl
Renewal 2022: Exom - eTMF - 162 sites - June to Aug -3 months
Closed Won
Q1-2023
100
87
4/22/2022
1/25/2022
Sales
Subscription
0015000000tptQnAAI
0015000000tptQnAAI
R&D
0015000000tptQn
Exom Group
19
4/26/2022
US Sales User - R&D SMB
Anthony Henry
Phil Sager
Immunocore, Ltd
Renewal 2022: Immunocore_Vault Submissions/Submissions Archive
Closed Won
Q1-2023
100
358
4/26/2022
5/3/2021
Sales
Renewal
0012J00002LO4EvQAL
0012J00002LO4EvQAL
Submissions; Submissions Archive
Vault
R&D
0012J00002LO4Ev
Immunocore, Ltd
20
4/27/2022
US Sales User - R&D SMB
Kelly Morrison
Jonathan Waldvogel
Cullinan Oncology
Renewal 2022: Cullinan Oncology - eTMF - (32)
Closed Won
Q1-2023
100
279
4/27/2022
7/23/2021
Renewal
0012J00002N4H28QAF
0012J00002N4H28QAF
eTMF
Vault
R&D
0012J00002N4H28
Cullinan Oncology
21
4/27/2022
JP Sales User - R&D ENT
Hajime Kosuge
Daiichi Sankyo Company, Limited. (Japan KK)
Renewal 2022: Daiichi Sankyo - CoMET eTMF ELA - JP/US/EU
Closed Won
Q1-2023
100
301
4/27/2022
7/1/2021
Renewal
0015000000aQnvWAAS
0012J00002MK4XEQA1
0012J00002MK4XEQA1
0012J00002MK4XEQA1
eTMF; QualityDocs; Submissions
Vault
R&D
0015000000aQnvW
0012J00002aX68D
Daiichi Sankyo Co.,LTD
22
4/27/2022
EU Sales User - R&D ENT
Jürgen Grampp
Novartis Pharma AG
Renewal 2022: Sandoz Biosimilars - eTMF
Closed Won
Q1-2023
100
181
4/27/2022
10/28/2021
Sales
Subscription
0015000001280zcAAA
0012J00002MIzmfQAD
0012J00002MIzmfQAD
0012J00002MIzmfQAD
R&D
0015000001280zc
001500000133m4p
The Medicines Company
23
4/28/2022
US Sales User - R&D SMB
Allie Grodin
Jim Thai
Vir Biotechnology, Inc.
Renewal 2022: Vir Bio RIM
Closed Won
Q1-2023
100
363
4/28/2022
5/1/2021
Renewal
0015000001S0gThAAJ
0015000001S0gThAAJ
Submissions; Submissions Archive
Vault
R&D
0015000001S0gTh
Vir Biotechnology
24
4/28/2022
US Sales User - R&D SMB
David Hockenberry
Adam De Oliveira
Kiniksa Pharmaceuticals Corp.
Renewal 2022: Kiniksa- RIM
Closed Won
Q1-2023
100
360
4/28/2022
5/3/2021
Renewal
0015000001HfFYcAAN
0015000001HfFYcAAN
Submissions; Submissions Archive
Vault
R&D
0015000001HfFYc
Kiniksa Pharmaceuticals Corp
25
4/28/2022
US Sales User - R&D SMB
Allie Grodin
Jim Thai
Vir Biotechnology, Inc.
Renewal 2022: Vir Bio QualityDocs & Training
Closed Won
Q1-2023
100
13
4/28/2022
4/15/2022
Subscription
0015000001S0gThAAJ
0015000001S0gThAAJ
R&D
0015000001S0gTh
Vir Biotechnology
26
4/29/2022
US Sales User - R&D SMB
Mary Molnar
Phil Sager
Sumitovant Biopharma, Inc.
Renewal 2022: Sumitovant Biopharma - Vault QualityDocs & Training
Closed Won
Q1-2023
100
373
4/29/2022
4/21/2021
Renewal
0012J00002OfD5XQAV
0012J00002MKw1cQAD
0012J00002MKw1cQAD
0012J00002MKw1cQAD
QualityDocs; Vault Training
Vault
R&D
0012J00002OfD5X
0012J00002MKw1c
SUMITOMO DAINIPPON PHARMA CO., LTD.
27
5/2/2022
US Sales User - R&D SMB
Allie Grodin
Jim Thai
Vir Biotechnology, Inc.
Renewal 2022: Vir Bio QMS - 100 Users
Closed Won
Q2-2023
100
17
5/2/2022
4/15/2022
Subscription
0015000001S0gThAAJ
0015000001S0gThAAJ
R&D
0015000001S0gTh
Vir Biotechnology
28
5/4/2022
US Sales User - R&D SMB
Krystal Kermott
Christopher Mundy
Lexicon Pharmaceuticals, Inc
Renewal 2022: Lexicon eTMF
Closed Won
Q2-2023
100
328
5/4/2022
6/10/2021
Renewal
0015000000Lq8CgAAJ
0015000000Lq8CgAAJ
eTMF
Vault
R&D
0015000000Lq8Cg
Lexicon Pharmaceuticals, Inc.
29
5/4/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Pharm-Olam, LLC
Renewal 2022: Pharm-Olam eTMF - 1109
Closed Won
Q2-2023
100
135
5/4/2022
12/20/2021
Subscription
0015000000LVmaPAAT
0015000000htJv3AAE
0015000000htJv3AAE
0015000000htJv3AAE
R&D
0015000000LVmaP
0015000000htJv3
Pharm-Olam International, LLC
30
5/4/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Pharm-Olam, LLC
Renewal 2022: Pharm-Olam eTMF - Orphan 1126 & 1108
Closed Won
Q2-2023
100
9
5/4/2022
4/25/2022
Subscription
0015000000LVmaPAAT
0015000000htJv3AAE
0015000000htJv3AAE
0015000000htJv3AAE
R&D
0015000000LVmaP
0015000000htJv3
Pharm-Olam International, LLC
31
5/5/2022
US Sales User - R&D SMB
Ashlynn Roth
Adam De Oliveira
Alimera Sciences, Inc.
Renewal 2022: Alimera RIM + QualityDocs ELA
Closed Won
Q2-2023
100
296
5/5/2022
7/13/2021
Renewal
0015000000QYShhAAH
0015000000QYShhAAH
Registrations; Submissions; Submissions Archive
Vault
R&D
0015000000QYShh
Alimera Sciences, Inc.
32
5/5/2022
US Sales User - R&D SMB
Abbe Macbeth
Phil Sager
Supernus Pharmaceuticals, Inc.
Renewal 2022: Supernus Pharma - Vault eTMF, eTMF Archive, CTMS, & Payments
Closed Won
Q2-2023
100
149
5/5/2022
12/7/2021
Sales
Subscription
0015000000PiLnMAAV
0015000000PiLnMAAV
R&D
0015000000PiLnM
Supernus Pharmaceuticals, Inc.
33
5/5/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Pharm-Olam, LLC
Renewal 2022: Pharm-Olam eTMF - 1212
Closed Won
Q2-2023
100
10
5/5/2022
4/25/2022
Subscription
0015000000LVmaPAAT
0015000000htJv3AAE
0015000000htJv3AAE
0015000000htJv3AAE
R&D
0015000000LVmaP
0015000000htJv3
Pharm-Olam International, LLC
34
5/9/2022
EU Sales User - R&D SMB
Reto Flury
Auregen BioTherapeutics SA
Renewal 2022: Auregen Biotherapeutics- Quality
Closed Won
Q2-2023
100
304
5/9/2022
7/9/2021
Renewal
0015000001XsdfDAAR
0015000001XsdfDAAR
QualityDocs
Vault
R&D
0015000001XsdfD
Auregen Biotherapeutics SA
35
5/10/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Pharm-Olam, LLC
Renewal 2022: Pharm-Olam eTMF - Valneva 4 Sites
Closed Won
Q2-2023
100
89
5/10/2022
2/10/2022
Subscription
0015000000LVmaPAAT
0015000000htJv3AAE
0015000000htJv3AAE
0015000000htJv3AAE
R&D
0015000000LVmaP
0015000000htJv3
Pharm-Olam International, LLC
36
5/10/2022
EU Sales User - R&D ENT
Katrien Mesotten
Kiadis Pharma Netherlands BV
Renewal 2022: Kiadis Pharma Netherlands BV - eTMF 33 sites - year 3- 3 months
Closed Won
Q2-2023
100
375
5/10/2022
5/1/2021
Renewal
00150000010hIesAAE
0015000001TVjdfAAD
0015000001TVjdfAAD
0015000001TVjdfAAD
eTMF
Vault
R&D
00150000010hIes
0015000001TVjdf
Bioverativ, Inc.
37
5/10/2022
EU Sales User - R&D ENT
Katrien Mesotten
Kiadis Pharma Netherlands BV
Renewal 2022: Kiadis Pharma - ELA 200 QD & 45 users QMS
Closed Won
Q2-2023
100
375
5/10/2022
5/1/2021
Renewal
00150000010hIesAAE
0015000001TVjdfAAD
0015000001TVjdfAAD
0015000001TVjdfAAD
QMS; QualityDocs
Vault
R&D
00150000010hIes
0015000001TVjdf
Bioverativ, Inc.
38
5/12/2022
US Sales User - R&D SMB
Kerri Klidas
Jim Thai
Omeros Corporation
Renewal 2022: Omeros - Sub/SubA - 10 Full, 10 Archive
Closed Won
Q2-2023
100
370
5/12/2022
5/7/2021
Renewal
0015000000aQgjUAAS
0015000000aQgjUAAS
Submissions
Vault
R&D
0015000000aQgjU
Omeros Corporation
39
5/12/2022
US Sales User - R&D SMB
Kerri Klidas
Jim Thai
Omeros Corporation
Renewal 2022: Omeros Vault QualityDocs - 300 ELA
Closed Won
Q2-2023
100
363
5/12/2022
5/15/2021
Renewal
0015000000aQgjUAAS
0015000000aQgjUAAS
QualityDocs
Vault
R&D
0015000000aQgjU
Omeros Corporation
40
5/12/2022
US Sales User - R&D SMB
Kerri Klidas
Jim Thai
Omeros Corporation
Renewal 2022: Omeros - QMS - 50 Full Users + 15 in future bucket
Closed Won
Q2-2023
100
437
5/12/2022
3/1/2021
Renewal
0015000000aQgjUAAS
0015000000aQgjUAAS
QMS
Vault
R&D
0015000000aQgjU
Omeros Corporation
41
5/13/2022
US Sales User - R&D SMB
Adam Sybrowsky
David Florez
Societal CDMO
Renewal 2022: Societal CDMO QualityDocs Renewal
Closed Won
Q2-2023
100
329
5/13/2022
6/19/2021
Renewal
0015000001P4J8XAAV
0015000001P4J8XAAV
QualityDocs
Vault
R&D
0015000001P4J8X
Societal CDMO
42
5/13/2022
US Sales User - CRO
Joey Sineno
Katie Tipton
Social & Scientific Systems, Inc.
Renewal 2022: S3 DMID-BET - Consolidated 61 Sites
Closed Won
Q2-2023
100
78
5/13/2022
2/24/2022
Subscription
0015000000tQUB1AAO
0015000000tQUB1AAO
R&D
0015000000tQUB1
Social & Scientific Systems, Inc.
43
5/17/2022
EU Sales User - R&D SMB
Raminta Baskyte
Laboratorios Hipra, S.A.
Hipra - Reg,Sub - Year 2 Renewal June 2022
Closed Won
Q2-2023
100
802
5/17/2022
3/6/2020
Sales
Subscription
0015000001EeMYvAAN
0015000001EeMYvAAN
Registrations; Submissions; Submissions Archive
Vault
R&D
0015000001EeMYv
Laboratorios Hipra
44
5/20/2022
US Sales User - CRO
Greyson McGrail
Katie Tipton
Spaulding Clinical Research, LLC
Renewal 2022: Spaulding Clinical Research - eTMF
Closed Won
Q2-2023
100
371
5/20/2022
5/15/2021
Renewal
00150000015LXQaAAO
00150000015LXQaAAO
eTMF
Vault
R&D
00150000015LXQa
Spaulding Clinical Research, LLC
45
5/20/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Atlantic Research Group, Inc.
Renewal 2022: Atlantic Research Group eTMF Full Account Renewal 6/1/2022
Closed Won
Q2-2023
100
95
5/20/2022
2/14/2022
Subscription
0015000000qIWUEAA4
0015000000qIWUEAA4
R&D
0015000000qIWUE
Atlantic Research Group, Inc.
46
5/20/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Atlantic Research Group, Inc.
Renewal 2022: Atlantic Research Group - CTMS
Closed Won
Q2-2023
100
95
5/20/2022
2/14/2022
Sales
Subscription
0015000000qIWUEAA4
0015000000qIWUEAA4
R&D
0015000000qIWUE
Atlantic Research Group, Inc.
47
5/23/2022
US Sales User - R&D SMB
Krystal Kermott
Christopher Mundy
Bellicum Pharmaceuticals Inc.
Renewal 2022: Bellicum Vault- Qdocs & eTMF
Closed Won
Q2-2023
100
355
5/23/2022
6/2/2021
Renewal
0015000000bhOLMAA2
0015000000bhOLMAA2
Submissions; Submissions Archive
Vault
R&D
0015000000bhOLM
Bellicum Pharmaceuticals, Inc.
48
5/23/2022
US Sales User - CRO
Joey Sineno
Katie Tipton
Paragon Bioteck, Inc.
Renewal 2022: Paragon Bioteck, Vault Submissions and SubmissionsArchive
Closed Won
Q2-2023
100
301
5/23/2022
7/26/2021
Renewal
0015000001KNAOJAA5
0015000001Dqpq2AAB
0015000001Dqpq2AAB
0015000001Dqpq2AAB
Submissions; Submissions Archive
Vault
R&D
0015000001KNAOJ
0015000001Dqpq2
Paragon Bioteck, Inc.
49
5/24/2022
US Sales User - R&D SMB
Ashlynn Roth
Adam De Oliveira
G1 Therapeutics, Inc.
Renewal 2022: G1-Sub-Quality-QMS-eTMF-Training- Platform
Closed Won
Q2-2023
100
385
5/24/2022
5/4/2021
Renewal
00150000019CZTNAA4
00150000019CZTNAA4
QualityDocs
Vault
R&D
00150000019CZTN
G1 Therapeutics, Inc.
50
5/24/2022
JP Sales User - R&D ENT
Junichiro Tomoda
The Research Foundation for Microbial Diseases of Osaka University
Renewal 2022: BIKEN QualityDocs
Closed Won
Q2-2023
100
363
5/24/2022
5/26/2021
Renewal
0015000001nyfi1AAA
0015000001nyfi1AAA
QualityDocs
Vault
R&D
0015000001nyfi1
The Research Foundation for Microbial Diseases of Osaka University
51
5/24/2022
JP Sales User - R&D ENT
Junichiro Tomoda
The Research Foundation for Microbial Diseases of Osaka University
Renewal 2022: BIKEN eTMF 43 Sites
Closed Won
Q2-2023
100
358
5/24/2022
6/1/2021
Renewal
0015000001nyfi1AAA
0015000001nyfi1AAA
eTMF
Vault
R&D
0015000001nyfi1
The Research Foundation for Microbial Diseases of Osaka University
52
5/26/2022
US Sales User - MedTech ENT
Casey Davidson
International Partnership for Microbicides, Inc.
Renewal 2022: IPM - eTMF - 30 Sites
Closed Won
Q2-2023
100
358
5/26/2022
6/2/2021
Sales
Renewal
0015000001RFZmPAAX
0015000001RFZmPAAX
eTMF
Vault
R&D
0015000001RFZmP
International Partnership for Microbicides
53
5/26/2022
US Sales User - MedTech SMB
Carla Foley
New Erie Scientific LLC
Renewal: Epredia RIM and Submissions for June 2021 through 5/31/22
Closed Won
Q2-2023
100
0
5/26/2022
5/26/2022
Sales
Subscription
0012J00002Pxs5BQAR
0012J00002PUCszQAH
0012J00002PUCszQAH
0012J00002PUCszQAH
R&D
0012J00002Pxs5B
0012J00002PUCsz
Ascensia Diabetes Care
54
5/27/2022
US Sales User - R&D SMB
Marta Considine
Adam De Oliveira
Avalo Therapeutics, Inc.
Renewal 2022: Avalo - Quality & RIM
Closed Won
Q2-2023
100
260
5/27/2022
9/9/2021
Renewal
0015000000htJuFAAU
0015000000htJuFAAU
QualityDocs; Vault Training
Vault
R&D
0015000000htJuF
Cerecor
55
5/27/2022
US Sales User - R&D ENT
Greg Boudreau
Takeda Development Center Americas, Inc.
Takeda Pharma - CTMS_SSU_Payments_Site Connect - Global - ELA Year 1
Closed Won
Q2-2023
100
120
5/27/2022
1/27/2022
Sales
Subscription
0012J00002aXg5vQAC
0012J00002LPydAQAT
0012J00002LPydAQAT
0012J00002LPydAQAT
R&D
0012J00002aXg5v
0012J00002MJsv2
Shire Pharmaceuticals Inc.
56
5/31/2022
US Sales User - MedTech ENT
Jeff Wheeler
New Erie Scientific LLC
Epredia RIM and Submissions for June 2022 through 5/31/23
Closed Won
Q2-2023
100
722
5/31/2022
6/8/2020
Renewal
0012J00002Pxs5BQAR
0012J00002PUCszQAH
0012J00002PUCszQAH
0012J00002PUCszQAH
Submissions; Submissions Archive
Vault
R&D
0012J00002Pxs5B
0012J00002PUCsz
Ascensia Diabetes Care
57
5/31/2022
US Sales User - R&D SMB
Chloe Kearns
Jim Thai
Nektar Therapeutics
Renewal 2022: Nektar Vault eTMF - 401 Active, 65 Archive
Closed Won
Q2-2023
100
350
5/31/2022
6/15/2021
Renewal
0015000000Lq8D5AAJ
0012J00002PUIc1QAH
0012J00002PUIc1QAH
0012J00002PUIc1QAH
eTMF
Vault
R&D
0015000000Lq8D5
0012J00002PUIc1
Nektar Therapeutics
58
5/31/2022
US Sales User - CRO
Joel Evans
InVentiv Health Clinical, LLC, a subsidiary of Syneos Health Inc
Renewal 2022: Syneos eTMF - 3YR ELA - (Year 2)
Closed Won
Q2-2023
100
335
5/31/2022
6/30/2021
Renewal
0012J00002KlvT8QAJ
0012J00002MKPWbQAP
0012J00002MKPWbQAP
0012J00002MKPWbQAP
eTMF
Vault
R&D
0012J00002KlvT8
0012J00002MKPWb
Inventiv
59
6/1/2022
US Sales User - R&D SMB
Jonathan Benzimra
Adam De Oliveira
Prolong Pharmaceuticals, LLC
Renewal 2022: Prolong - Vault QualityDocs,QMS
Closed Won
Q2-2023
100
393
6/1/2022
5/4/2021
Renewal
0015000000bhOKvAAM
0015000000bhOKvAAM
QualityDocs
Vault
R&D
0015000000bhOKv
Prolong Pharmaceuticals, LLC
60
6/1/2022
US Sales User - CRO
Greyson McGrail
Katie Tipton
Technical Resources International, Inc.
Renewal 2022: TRI eTMF 6-1-2022
Closed Won
Q2-2023
100
169
6/1/2022
12/14/2021
Subscription
0015000000olZKlAAM
0015000000olZKlAAM
R&D
0015000000olZKl
Technical Resources International, Inc.
61
6/2/2022
US Sales User - R&D SMB
Mary Molnar
Phil Sager
Arvinas Operations, Inc
Renewal 2022: Arvinas - QDocs & Training & Subs/SubsA
Closed Won
Q2-2023
100
336
6/2/2022
7/1/2021
Renewal
0015000001MaGUTAA3
0015000001MaGUTAA3
QualityDocs; Vault Training
Vault
R&D
0015000001MaGUT
Arvinas
62
6/2/2022
CN Sales User - R&D ENT
Stephanie Zhang
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Renewal Jun 2023: Dizal-China Biotech-QD+TRN-ELA250
Closed Won
Q2-2023
100
0
6/2/2022
6/2/2022
Sales
Subscription
0012J00002RDkCgQAL
0012J00002QK82jQAD
0012J00002QK82jQAD
0012J00002QK82jQAD
R&D
0012J00002RDkCg
0012J00002QK82j
Dizal Pharmaceutical
63
6/2/2022
CN Sales User - R&D ENT
Stephanie Zhang
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Renewal Jun 2024: Dizal-China Biotech-QD+TRN-ELA250
Closed Won
Q2-2023
100
0
6/2/2022
6/2/2022
Sales
Subscription
0012J00002RDkCgQAL
0012J00002QK82jQAD
0012J00002QK82jQAD
0012J00002QK82jQAD
R&D
0012J00002RDkCg
0012J00002QK82j
Dizal Pharmaceutical
64
6/6/2022
US Sales User - R&D SMB
Seth Fox
David Florez
Coherus BioSciences, Inc.
Renewal 2022: Coherus - RIM (Subs/SubsA)
Closed Won
Q2-2023
100
102
6/6/2022
2/24/2022
Subscription
0015000000tq1wMAAQ
0015000000tq1wMAAQ
R&D
0015000000tq1wM
Coherus Biosciences, Inc.
65
6/9/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Pharm-Olam, LLC
Renewal 2022: Pharm-Olam eTMF 1154
Closed Won
Q2-2023
100
171
6/9/2022
12/20/2021
Sales
Subscription
0015000000LVmaPAAT
0015000000htJv3AAE
0015000000htJv3AAE
0015000000htJv3AAE
R&D
0015000000LVmaP
0015000000htJv3
Pharm-Olam International, LLC
66
6/9/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Pharm-Olam, LLC
Renewal 2022: Pharm-Olam eTMF 1082
Closed Won
Q2-2023
100
7
6/9/2022
6/2/2022
Sales
Subscription
0015000000LVmaPAAT
0015000000htJv3AAE
0015000000htJv3AAE
0015000000htJv3AAE
R&D
0015000000LVmaP
0015000000htJv3
Pharm-Olam International, LLC
67
6/9/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Pharm-Olam, LLC
Renewal 2022: Pharm-Olam eTMF 1166
Closed Won
Q2-2023
100
7
6/9/2022
6/2/2022
Sales
Subscription
0015000000LVmaPAAT
0015000000htJv3AAE
0015000000htJv3AAE
0015000000htJv3AAE
R&D
0015000000LVmaP
0015000000htJv3
Pharm-Olam International, LLC
68
6/9/2022
EU Sales User - R&D SMB
Rachel Rees
GlaxoSmithKline LLC
GSK Consumer Vault QMS P3 Renewal
Closed Won
Q2-2023
100
699
6/9/2022
7/10/2020
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
QMS
Vault
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
69
6/16/2022
US Sales User - CRO
Joey Sineno
Katie Tipton
Social & Scientific Systems, Inc.
Renewal 2022: S3 DMID-BET - Consolidated 61 Sites
Closed Won
Q2-2023
100
34
6/16/2022
5/13/2022
Subscription
0015000000tQUB1AAO
0015000000tQUB1AAO
R&D
0015000000tQUB1
Social & Scientific Systems, Inc.
70
6/17/2022
JP Sales User - R&D ENT
Hajime Kosuge
Daiichi Sankyo Company, Limited. (Japan KK)
Renewal 2022: Daiichi Sankyo - CoMET Subs ELA & Subs Archive 6th Year - JP/US
Closed Won
Q2-2023
100
353
6/17/2022
6/29/2021
Renewal
0015000000aQnvWAAS
0012J00002MK4XEQA1
0012J00002MK4XEQA1
0012J00002MK4XEQA1
eTMF; QualityDocs; Submissions
Vault
R&D
0015000000aQnvW
0012J00002aX68D
Daiichi Sankyo Co.,LTD
71
6/19/2022
EU Sales User - R&D SMB
Jeremy Cottin
ERYTECH Pharma S.A
Renewal 2022: Erytech - QMS - ELA300- Year 1 + ramp
Closed Won
Q2-2023
100
376
6/19/2022
6/8/2021
Sales
Subscription
00150000019s0WQAAY
00150000019s0WQAAY
QMS
Vault
R&D
00150000019s0WQ
Erytech
72
6/21/2022
EU Sales User - R&D SMB
Rachel Rees
GlaxoSmithKline LLC
Renewal 2022: GSK Biopharma QualityDocs ELA
Closed Won
Q2-2023
100
147
6/21/2022
1/25/2022
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
73
6/22/2022
US Sales User - R&D SMB
Emily Rollet
Ernie Chin
Purdue Pharma L.P.
Renewal 2022: Purdue/Imbrium - Vault Submissions - 60 users
Closed Won
Q2-2023
100
326
6/22/2022
8/1/2021
Renewal
0015000000IO284AAD
0015000000IO284AAD
Submissions
Vault
R&D
0015000000IO284
Purdue Pharma L.P.
74
6/22/2022
US Sales User - R&D SMB
Ashlynn Roth
Adam De Oliveira
G1 Therapeutics, Inc.
Renewal 2022: G1 Therapeutics - Safety (4 month renewal)
Closed Won
Q2-2023
100
104
6/22/2022
3/10/2022
Sales
Subscription
00150000019CZTNAA4
00150000019CZTNAA4
R&D
00150000019CZTN
G1 Therapeutics, Inc.
75
6/22/2022
EU Sales User - CDMS
Greet Van Thillo
European Organisation for Research and Treatment of Cancer
Renewal 2022: EORTC QMS ELA 300
Closed Won
Q2-2023
100
295
6/22/2022
9/1/2021
Renewal
0015000000wyMo2AAE
0015000000wyMo2AAE
QMS
Vault
R&D
0015000000wyMo2
EORTC
76
6/23/2022
US Sales User - MedTech ENT
Alyssa Martucci
New Erie Scientific LLC
Renewal: Epredia Vault Qdocs_ Runcorn 50 Full Users term 3
Closed Won
Q2-2023
100
507
6/23/2022
2/1/2021
Sales
Subscription
0012J00002Pxs5BQAR
0012J00002PUCszQAH
0012J00002PUCszQAH
0012J00002PUCszQAH
QualityDocs
Vault
R&D
0012J00002Pxs5B
0012J00002PUCsz
Ascensia Diabetes Care
77
6/27/2022
US Sales User - R&D SMB
Julie Bolger
Ernie Chin
Amarin Pharma Inc.
Renewal 2022: Amarin Corp_Vault Submissions/Submissions Archive
Closed Won
Q2-2023
100
317
6/27/2022
8/15/2021
Renewal
0015000000UlZyYAAV
0015000000MMajDAAT
0015000000MMajDAAT
0015000000MMajDAAT
Submissions; Submissions Archive
Vault
R&D
0015000000UlZyY
0015000000MMajD
Amarin Corporation (US Headquarters)
78
6/28/2022
Asia Pac Sales User - R&D SMB
Sean Cho
Medytox Co., LTD.
Renewal Jul 2024: Medytox_KR_QMS_ELA500_Year3
Closed Won
Q2-2023
100
1
6/28/2022
6/27/2022
Sales
Subscription
0012J00002bQTRdQAO
0015000001KNJtiAAH
0015000001KNJtiAAH
0015000001KNJtiAAH
R&D
0012J00002bQTRd
0015000001KNJti
MEDYTOX
79
6/30/2022
EU Sales User - R&D ENT
Jürgen Grampp
Genentech, Inc.
Roche Pharma RIM Suite Y3 Renewal (EU)
Closed Won
Q2-2023
100
707
6/30/2022
7/23/2020
Marketing
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
Registrations
Vault
R&D
0015000000IO27U
0015000001nyFxK
Chugai Pharmaceutical Co.,Ltd.
80
6/30/2022
EU Sales User - R&D ENT
Jürgen Grampp
Genentech, Inc.
Roche Pharma PT - Vault QMS - EU-Yr 3 Renewal
Closed Won
Q2-2023
100
707
6/30/2022
7/23/2020
Sales
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
QMS
Vault
R&D
0015000000IO27U
0015000001nyFxK
Chugai Pharmaceutical Co.,Ltd.
81
6/30/2022
US Manager - MedTech Sales
John Vorwerk
Genentech, Inc.
Roche Pharma RIM Suite Yr 3 Renewal (US)
Closed Won
Q2-2023
100
707
6/30/2022
7/23/2020
Marketing
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
Registrations
Vault
R&D
0015000000IO27U
0015000001nyFxK
Chugai Pharmaceutical Co.,Ltd.
82
6/30/2022
US Manager - MedTech Sales
John Vorwerk
Genentech, Inc.
Roche Pharma PT - Vault QMS - US-Yr 3 Renewal
Closed Won
Q2-2023
100
707
6/30/2022
7/23/2020
Sales
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
QMS
Vault
R&D
0015000000IO27U
0015000001nyFxK
Chugai Pharmaceutical Co.,Ltd.
83
7/1/2022
US Sales User - R&D SMB
Mariah Lewis
Jim Thai
Turning Point Therapeutics, Inc.
Turning Point Therapeutics - QualityDocs and Training - ELA 300 (Ramp Yr. 1, Period 2)
Closed Won
Q2-2023
100
164
7/1/2022
1/18/2022
Sales
Subscription
0015000001eME6lAAG
0015000001eME6lAAG
R&D
0015000001eME6l
Turning Point Therapeutics, Inc.
84
7/1/2022
US Manager - MedTech Sales
John Vorwerk
Genentech, Inc.
Roche Pharma Publishing-US/EU-Yr 1 Renewal
Closed Won
Q2-2023
100
277
7/1/2022
9/27/2021
Sales
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
Submissions Publishing
Vault
R&D
0015000000IO27U
0015000001nyFxK
Chugai Pharmaceutical Co.,Ltd.
85
7/1/2022
US Sales User - MedTech ENT
Bryan Federici
Foundation Medicine, Inc.
FMI Year 2 ELA for QMS & QDocs
Closed Won
Q2-2023
100
317
7/1/2022
8/18/2021
Sales
Subscription
0015000000ddJezAAE
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
QMS; QualityDocs
Vault
R&D
0015000000ddJez
0012J00002ZERRv
Chugai Pharmaceutical Co.,Ltd.
86
7/3/2022
Asia Pac Sales User - R&D ENT
Amber Lee
SillaJen, Inc.
Renewal 2022: Sillajen - Vault QualityDocs - 50 Employee ELA
Closed Won
Q2-2023
100
368
7/3/2022
7/1/2021
Renewal
0015000002GVFnkAAH
0015000002GVFnkAAH
QualityDocs
Vault
R&D
0015000002GVFnk
Sillajen Biotherapeutics, Inc.
87
7/3/2022
Asia Pac Sales User - R&D ENT
Amber Lee
SillaJen, Inc.
Renewal 2022: Sillajen - Vault eTMF & CTMS
Closed Won
Q2-2023
100
337
7/3/2022
8/1/2021
Renewal
0015000002GVFnkAAH
0015000002GVFnkAAH
eTMF
Vault
R&D
0015000002GVFnk
Sillajen Biotherapeutics, Inc.
88
7/6/2022
EU Sales User - R&D SMB
Rachel Mc Hugh
GW Research Limited
Renewal 2022: GW eTMF
Closed Won
Q2-2023
100
389
7/6/2022
6/13/2021
Renewal
0015000000ePga4AAC
0012J00002MKw19QAD
0012J00002MKw19QAD
0012J00002MKw19QAD
eTMF
Vault
R&D
0015000000ePga4
0012J00002MKw19
Jazz Pharmaceuticals, Inc.
89
7/6/2022
US Sales User - R&D SMB
Adham Chebbani
Jonathan Waldvogel
Homology Medicines Inc.
Renewal 2022: Homology RIM
Closed Won
Q2-2023
100
363
7/6/2022
7/9/2021
Renewal
0015000001XrfCWAAZ
0015000001XrfCWAAZ
Submissions; Submissions Archive
Vault
R&D
0015000001XrfCW
Homology Medicines Inc.
90
7/6/2022
US Sales User - R&D SMB
David Hockenberry
Adam De Oliveira
Kiniksa Pharmaceuticals Corp.
Renewal 2022: Kiniksa Pharmaceuticals - eTMF
Closed Won
Q2-2023
100
335
7/6/2022
8/5/2021
Renewal
0015000001HfFYcAAN
0015000001HfFYcAAN
eTMF
Vault
R&D
0015000001HfFYc
Kiniksa Pharmaceuticals Corp
91
7/7/2022
US Sales User - R&D SMB
Adham Chebbani
Jonathan Waldvogel
Homology Medicines Inc.
Renewal 2022: Homology Medicines - Quality & Training ELA 200 #NC
Closed Won
Q2-2023
100
364
7/7/2022
7/9/2021
Renewal
0015000001XrfCWAAZ
0015000001XrfCWAAZ
QualityDocs; Station Manager
Vault
R&D
0015000001XrfCW
Homology Medicines Inc.
92
7/8/2022
EU Sales User - R&D ENT
Zoltan Szarka
GlaxoSmithKline LLC
Renewal 2022: Tesaro GSK QMS 3 months
Closed Won
Q2-2023
100
233
7/8/2022
11/17/2021
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
93
7/11/2022
US Sales User - CRO
Joey Sineno
Katie Tipton
Social & Scientific Systems, Inc.
Renewal Jul 2022: S3 DMID-BET - Consolidated 61 Sites
Closed Won
Q2-2023
100
25
7/11/2022
6/16/2022
Subscription
0015000000tQUB1AAO
0015000000tQUB1AAO
R&D
0015000000tQUB1
Social & Scientific Systems, Inc.
94
7/11/2022
JP Sales User - R&D ENT
Junichiro Tomoda
Sumitomo Pharma Co., Ltd.
Renewal 2022: SMP Clinical QMS 25 users
Closed Won
Q2-2023
100
345
7/11/2022
8/1/2021
Renewal
0015000000ORqoNAAT
0012J00002MKw1cQAD
0012J00002MKw1cQAD
0012J00002MKw1cQAD
QMS
Vault
R&D
0015000000ORqoN
0012J00002MKw2r
SUMITOMO DAINIPPON PHARMA CO., LTD.
95
7/12/2022
EU Sales User - R&D ENT
Maxime Orain
Sanofi Aventis Groupe
2024 Renewal: Sanofi - QDocs QMS Training ELA
Closed Won
Q2-2023
100
368
7/12/2022
7/9/2021
Renewal
0015000000Kjce7AAB
0015000001TVjdfAAD
0015000001TVjdfAAD
0015000001TVjdfAAD
QualityDocs
Vault
R&D
0015000000Kjce7
0012J00002bz91p
Bioverativ, Inc.
96
7/12/2022
EU Sales User - R&D ENT
Maxime Orain
Sanofi Aventis Groupe
2023 Renewal: Sanofi - QDocs QMS Training ELA
Closed Won
Q2-2023
100
1596
7/12/2022
2/27/2018
Sales
Subscription
0015000000Kjce7AAB
0015000001TVjdfAAD
0015000001TVjdfAAD
0015000001TVjdfAAD
QualityDocs
Vault
R&D
0015000000Kjce7
0012J00002bz91p
Bioverativ, Inc.
97
7/13/2022
US Sales User - R&D SMB
David Moneuse
Phil Sager
Mimedx Group, Inc.
Renewal 2022: MiMedx - Vault eTMF, CTMS, & Payments
Closed Won
Q2-2023
100
345
7/13/2022
8/2/2021
Renewal
0015000001EIny5AAD
0015000001EIny5AAD
Submissions; Submissions Archive
Vault
R&D
0015000001EIny5
Mimedx Group
98
7/13/2022
US Sales User - R&D SMB
David Moneuse
Phil Sager
Mimedx Group, Inc.
Renewal 2022: MiMedx - Submissions and Submissions Archive
Closed Won
Q2-2023
100
89
7/13/2022
4/15/2022
Subscription
0015000001EIny5AAD
0015000001EIny5AAD
R&D
0015000001EIny5
Mimedx Group
99
7/14/2022
US Sales User - R&D SMB
Ashlynn Roth
Adam De Oliveira
TherapeuticsMD, Inc.
TherapeuticsMD New SubmissionsArchive - 4Month renewal
Closed Won
Q2-2023
100
324
7/14/2022
8/24/2021
Sales
Subscription
0015000000dbU1sAAE
0015000000dbU1sAAE
Submissions Archive
Vault
R&D
0015000000dbU1s
TherapeuticsMD, Inc
100
7/19/2022
US Sales User - R&D SMB
Kelly Morrison
Jonathan Waldvogel
Repertoire Immune Medicines
Renewal 2022: Repertoire - eTMF #NC
Closed Won
Q2-2023
100
309
7/19/2022
9/13/2021
Renewal
0012J00002P8I3DQAV
0012J00002P8I3DQAV
eTMF
Vault
R&D
0012J00002P8I3D
Repertoire Immune Medicines
101
7/19/2022
US Sales User - CRO
Greyson McGrail
Katie Tipton
Technical Resources International, Inc.
Renewal 2022: TRI Vault Submissions 7-1-2022
Closed Won
Q2-2023
100
242
7/19/2022
11/19/2021
Subscription
0015000000olZKlAAM
0015000000olZKlAAM
R&D
0015000000olZKl
Technical Resources International, Inc.
102
7/19/2022
US Sales User - R&D SMB
Will Gould
Jonathan Waldvogel
Amylyx Pharmaceuticals, Inc
Amylyx - QualityDocs & Training (Yr. 2)
Closed Won
Q2-2023
100
127
7/19/2022
3/14/2022
Sales
Subscription
0012J00002P4o1TQAR
0012J00002P4o1TQAR
R&D
0012J00002P4o1T
Amylyx Pharmaceuticals, Inc
103
7/20/2022
US Sales User - R&D SMB
Hillary Hornbeck
Ernie Chin
Jazz Pharmaceuticals, Inc.
Renewal 2022: Jazz Pharmaceuticals - Vault eTMF
Closed Won
Q2-2023
100
387
7/20/2022
6/28/2021
Renewal
0015000000IO27gAAD
0012J00002MKw19QAD
0012J00002MKw19QAD
0012J00002MKw19QAD
eTMF
Vault
R&D
0015000000IO27g
0012J00002bzPP2
Jazz Pharmaceuticals, Inc.
104
7/20/2022
US Sales User - R&D SMB
Anthony Gotzis
J&J Pharmaceuticals
Renewal 2022: Momenta RIM, QD, QMS, Training ELA200
Closed Won
Q2-2023
100
113
7/20/2022
3/29/2022
Subscription
0012J00002MJmrHQAT
0015000001RO8AFAA1
0015000001RO8AFAA1
0015000001RO8AFAA1
R&D
0012J00002MJmrH
0015000001RO8AF
Momenta Pharmaceuticals, Inc.
105
7/20/2022
LatAm Sales User
Luis Fernandez
Específicos Stendhal S.A de C.V.
Renewal 2022: Stendhal LatAm Registrations 10 Users
Closed Won
Q2-2023
100
415
7/20/2022
6/1/2021
Renewal
0015000000fTHSgAAO
0012J00002K4P7SQAV
0012J00002K4P7SQAV
0012J00002K4P7SQAV
Registrations; Submissions
Vault
R&D
0015000000fTHSg
0012J00002K4P7S
Espec�ficos Stendhal S.A de C.V.
106
7/21/2022
US Sales User - R&D SMB
Alana Wirt
Adam De Oliveira
International AIDS Vaccine Initiative, Inc.
Renewal 2022: IAVI - NA - eTMF
Closed Won
Q2-2023
100
97
7/21/2022
4/15/2022
Subscription
00150000019DKfQAAW
00150000019DKfQAAW
R&D
00150000019DKfQ
Aeras Global Tb Vaccine Foundation
107
7/22/2022
US Sales User - R&D SMB
Krystal Kermott
Christopher Mundy
Sorrento Therapeutics, Inc.
Renewal 2022: Sorrento Therapeutics - Vault Submissions/Submissions Archive
Closed Won
Q2-2023
100
377
7/22/2022
7/11/2021
Renewal
00150000013SNjAAAW
00150000013SNjAAAW
Registrations; Submissions
Vault
R&D
00150000013SNjA
Sorrento Therapeutics, Inc.
108
7/22/2022
EU Sales User - CDMS
Sam Rolfe
Exom Group Srl
Renewal 2022: Exom - eTMF - 162 sites - Sept -Nov 3 months
Closed Won
Q2-2023
100
91
7/22/2022
4/22/2022
Sales
Subscription
0015000000tptQnAAI
0015000000tptQnAAI
R&D
0015000000tptQn
Exom Group
109
7/28/2022
US Sales User - R&D ENT
Samantha Sykora
Audentes Therapeutics, Inc.
Renewal 2022: Audentes Therapeutics-QMS-300 ELA *
Closed Won
Q2-2023
100
346
7/28/2022
8/16/2021
Renewal
0015000000sDkKcAAK
0012J00002N44FaQAJ
0012J00002N44FaQAJ
0012J00002N44FaQAJ
QMS
Vault
R&D
0015000000sDkKc
0012J00002N44Fa
Audentes Therapeutics, Inc.
110
7/29/2022
US Sales User - R&D SMB
David Hockenberry
Adam De Oliveira
Strongbridge U.S. Inc.
Renewal 2022: Strongbridge Quality (QualityDocs & QMS)
Closed Won
Q2-2023
100
424
7/29/2022
6/1/2021
Renewal
00150000016BpEmAAK
00150000018Qz0AAAS
00150000018Qz0AAAS
00150000018Qz0AAAS
QualityDocs
Vault
R&D
00150000016BpEm
00150000018Qz0A
Strongbridge Biopharma plc
111
7/29/2022
EU Sales User - R&D SMB
Davide Pesenti
Recordati Rare Diseases, Inc.
Renewal 2022: Recordati US- Vault Training - 153 users
Closed Won
Q2-2023
100
365
7/29/2022
7/29/2021
Renewal
0015000000pJSINAA4
0015000000VSdDeAAL
0015000000VSdDeAAL
0015000000VSdDeAAL
Vault Training
Vault
R&D
0015000000pJSIN
0015000000VSdDe
Recordati Rare Diseases, Inc.
112
8/3/2022
EU Sales User - R&D ENT
Jürgen Grampp
Novartis
Renewal 2023: Novartis eTMF, Vault SSU
Closed Won
Q3-2023
100
1
8/3/2022
8/2/2022
Sales
Subscription
0012J00002MIzmfQAD
0012J00002MIzmfQAD
R&D
0012J00002MIzmf
The Medicines Company
113
8/3/2022
EU Sales User - R&D ENT
Jürgen Grampp
Novartis
Renewal 2024: Novartis eTMF, Vault SSU
Closed Won
Q3-2023
100
1
8/3/2022
8/2/2022
Sales
Subscription
0012J00002MIzmfQAD
0012J00002MIzmfQAD
R&D
0012J00002MIzmf
The Medicines Company
114
8/3/2022
EU Sales User - R&D ENT
Jürgen Grampp
Novartis
Renewal 2025: Novartis eTMF, Vault SSU
Closed Won
Q3-2023
100
1
8/3/2022
8/2/2022
Sales
Subscription
0012J00002MIzmfQAD
0012J00002MIzmfQAD
R&D
0012J00002MIzmf
The Medicines Company
115
8/3/2022
EU Sales User - R&D ENT
Jürgen Grampp
Novartis
Renewal 2026: Novartis eTMF, Vault SSU
Closed Won
Q3-2023
100
0
8/3/2022
8/3/2022
Sales
Subscription
0012J00002MIzmfQAD
0012J00002MIzmfQAD
R&D
0012J00002MIzmf
The Medicines Company
116
8/5/2022
US Sales User - R&D SMB
Adham Chebbani
Jonathan Waldvogel
Homology Medicines Inc.
Renewal 2022: Homology eTMF
Closed Won
Q3-2023
100
393
8/5/2022
7/9/2021
Renewal
0015000001XrfCWAAZ
0015000001XrfCWAAZ
eTMF
Vault
R&D
0015000001XrfCW
Homology Medicines Inc.
117
8/10/2022
US Sales User - R&D SMB
Jonathan Benzimra
Adam De Oliveira
Nevakar, Inc.
Renewal 2022: Nevakar - Vault RIM
Closed Won
Q3-2023
100
309
8/10/2022
10/5/2021
Renewal
0015000001TU8VKAA1
0015000001TU8VKAA1
Submissions; Submissions Archive
Vault
R&D
0015000001TU8VK
Nevakar, inc.
118
8/10/2022
US Manager - R&D Sales
Christopher Mundy
Christopher Mundy
Denovo Biopharma LLC
Renewal 2022: Denovo (formerly Tocagen) eTMF, Sub & Archive
Closed Won
Q3-2023
100
400
8/10/2022
7/6/2021
Renewal
00150000025afp4AAA
00150000025afp4AAA
eTMF; QualityDocs; Submissions
Vault
R&D
00150000025afp4
Denovo Biopharma LLC
119
8/16/2022
US Sales User - R&D SMB
David Moneuse
Phil Sager
Biocryst Pharmaceuticals, Inc.
Renewal 2022: Biocryst Pharmaceuticals - Vault CTMS/eTMF - Orphan Sites
Closed Won
Q3-2023
100
377
8/16/2022
8/4/2021
Renewal
0015000000Lq8AvAAJ
0015000000Lq8AvAAJ
eTMF
Vault
R&D
0015000000Lq8Av
Biocryst Pharmaceuticals, Inc.
120
8/16/2022
EU Sales User - R&D ENT
Zoltan Szarka
Genentech, Inc.
Roche Vault Payments - Y2
Closed Won
Q3-2023
100
637
8/16/2022
11/17/2020
Sales
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
CTMS
Vault
R&D
0015000000IO27U
0015000001nyFxK
Chugai Pharmaceutical Co.,Ltd.
121
8/16/2022
EU Sales User - R&D ENT
Zoltan Szarka
Genentech, Inc.
Roche Vault Payments - Y3
Closed Won
Q3-2023
100
50
8/16/2022
6/27/2022
Sales
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
R&D
0015000000IO27U
0015000001nyFxK
Chugai Pharmaceutical Co.,Ltd.
122
8/19/2022
US Sales User - R&D SMB
Jonathan Benzimra
Adam De Oliveira
Tiziana Life Sciences plc
Renewal 2022: Tiziana Life Sciences_Vault RIM (Submissions/Submissions Archive)
Closed Won
Q3-2023
100
324
8/19/2022
9/29/2021
Renewal
0012J00002LQ6AYQA1
0012J00002LQ6AYQA1
Submissions; Submissions Archive
Vault
R&D
0012J00002LQ6AY
Tiziana Life Sciences plc
123
8/19/2022
US Sales User - R&D SMB
Kelly Morrison
Jonathan Waldvogel
WAVE Life Sciences Ltd.
Renewal 2022: Wave Life Sciences- Contract Management (Platform)
Closed Won
Q3-2023
100
364
8/19/2022
8/21/2021
Renewal
001500000189NO7AAM
001500000189NO7AAM
Platform R&D
Vault
R&D
001500000189NO7
Wave Life Sciences
124
8/19/2022
EU Sales User - R&D SMB
Rachel Mc Hugh
GW Research Limited
Renewal 2022: GW Pharma QualityDocs & QMS - ELA500
Closed Won
Q3-2023
100
355
8/19/2022
8/30/2021
Renewal
0015000000ePga4AAC
0012J00002MKw19QAD
0012J00002MKw19QAD
0012J00002MKw19QAD
QualityDocs
Vault
R&D
0015000000ePga4
0012J00002MKw19
Jazz Pharmaceuticals, Inc.
125
8/22/2022
US Sales User - R&D SMB
David Hockenberry
Adam De Oliveira
Braeburn Inc.
Renewal 2022: Braeburn Vault Submissions/Submissions Archive
Closed Won
Q3-2023
100
342
8/22/2022
9/14/2021
Renewal
0015000000jYgnuAAC
0015000000jYgnuAAC
Submissions
Vault
R&D
0015000000jYgnu
Braeburn Inc.
126
8/22/2022
US Sales User - R&D SMB
Mary Molnar
Phil Sager
Roivant Sciences, Inc.
Renewal 2022: Roivant Sciences - Vault RIM, Quality, eTMF
Closed Won
Q3-2023
100
368
8/22/2022
8/19/2021
Renewal
0015000001APsQwAAL
0015000001APsQwAAL
eTMF; QMS; QualityDocs; Submissions; Submissions Archive; Vault Training
Vault
R&D
0015000001APsQw
Dermavant Sciences
127
8/22/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Atlantic Research Group, Inc.
Renewal 2022: Atlantic Research Group - CTMS
Closed Won
Q3-2023
100
94
8/22/2022
5/20/2022
Sales
Subscription
0015000000qIWUEAA4
0015000000qIWUEAA4
R&D
0015000000qIWUE
Atlantic Research Group, Inc.
128
8/22/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Atlantic Research Group, Inc.
Renewal 2022: Atlantic Research Group eTMF Full Account Renewal 9/1/2022
Closed Won
Q3-2023
100
94
8/22/2022
5/20/2022
Subscription
0015000000qIWUEAA4
0015000000qIWUEAA4
R&D
0015000000qIWUE
Atlantic Research Group, Inc.
129
8/22/2022
EU Sales User - R&D SMB
Rachel Mc Hugh
GW Research Limited
Renewal 2022: GW Pharma QualityDocs 6 months courtesy for migration access
Closed Won
Q3-2023
100
31
8/22/2022
7/22/2022
Subscription
0015000000ePga4AAC
0012J00002MKw19QAD
0012J00002MKw19QAD
0012J00002MKw19QAD
R&D
0015000000ePga4
0012J00002MKw19
Jazz Pharmaceuticals, Inc.
130
8/23/2022
US Sales User - R&D SMB
Russell Moeai
Christopher Mundy
Theravance Biopharma US, Inc.
Renewal 2022: Theravance - Subs 20 users/SubsA 10 users
Closed Won
Q3-2023
100
371
8/23/2022
8/17/2021
Sales
Renewal
0015000000LX0LMAA1
0015000000LX0LMAA1
Submissions; Submissions Archive
Vault
R&D
0015000000LX0LM
Theravance Biopharma US, Inc.
131
8/23/2022
CN Sales User - R&D ENT
Stephanie Zhang
TAIZHOU EOC pharma Co.,ltd
Renewal Aug 2023: EOCpharma-China-eTMF+CTMS-China Biotech ELA 5
Closed Won
Q3-2023
100
0
8/23/2022
8/23/2022
Sales
Subscription
0012J00002aZ3sPQAS
0015000000tsIxGAAU
0015000000tsIxGAAU
0015000000tsIxGAAU
R&D
0012J00002aZ3sP
0015000000tsIxG
Ceclor
132
8/23/2022
CN Sales User - R&D ENT
Stephanie Zhang
TAIZHOU EOC pharma Co.,ltd
Renewal Aug 2024: EOCpharma-China-eTMF+CTMS-China Biotech ELA 5
Closed Won
Q3-2023
100
0
8/23/2022
8/23/2022
Sales
Subscription
0012J00002aZ3sPQAS
0015000000tsIxGAAU
0015000000tsIxGAAU
0015000000tsIxGAAU
R&D
0012J00002aZ3sP
0015000000tsIxG
Ceclor
133
8/24/2022
US Sales User - R&D SMB
Caroline Barry
Jonathan Waldvogel
Vedanta Biosciences, Inc.
Renewal 2022: Vedanta - QualityDocs & Training ELA - QMS 30 Users
Closed Won
Q3-2023
100
348
8/24/2022
9/11/2021
Renewal
0015000001JGoyaAAD
0015000001JGoyaAAD
QMS; QualityDocs
Vault
R&D
0015000001JGoya
Vedanta Biosciences, Inc.
134
8/24/2022
EU Sales User - R&D SMB
Rachel Mc Hugh
Jazz
Renewal 2022: Jazz Pharmaceuticals Vault QualityDocs and QMS ELA 3,500
Closed Won
Q3-2023
100
191
8/24/2022
2/14/2022
Sales
Subscription
0012J00002MKw19QAD
0012J00002MKw19QAD
R&D
0012J00002MKw19
Jazz Pharmaceuticals, Inc.
135
8/24/2022
EU Sales User - R&D SMB
Reto Flury
Ferring International Center SA
Ferring - Vault Registrations - PUPM Year 2
Closed Won
Q3-2023
100
488
8/24/2022
4/23/2021
Sales
Subscription
0015000000aQAuPAAW
0012J00002MKF7XQAX
0012J00002MKF7XQAX
0012J00002MKF7XQAX
Registrations; Submissions; Submissions Archive
Vault
R&D
0015000000aQAuP
0012J00002MKF7X
FerGene
136
8/25/2022
US Sales User - R&D SMB
Mariah Lewis
Jim Thai
Arcturus Therapeutics, Inc.
Renewal 2022: Arcturus Therapeutics - Vault QualityDocs & Vault Training - 200 ELA
Closed Won
Q3-2023
100
363
8/25/2022
8/27/2021
Renewal
0015000000r8H7sAAE
0015000000r8H7sAAE
QualityDocs; Vault Training
Vault
R&D
0015000000r8H7s
Arcturus Therapeutics, Inc.
137
8/25/2022
EU Sales User - R&D SMB
Sarah Kemkes
MorphoSys AG
Renewal 2022 Morphosys - RIM ELA 1000
Closed Won
Q3-2023
100
218
8/25/2022
1/19/2022
Sales
Subscription
0015000000OQ3L7AAL
0015000000OQ3L7AAL
R&D
0015000000OQ3L7
MorphoSys AG
138
8/26/2022
US Sales User - CRO
Greyson McGrail
Katie Tipton
ASH Research Collaborative
Renewal 2022: ASH - eTMF - 52 Sites
Closed Won
Q3-2023
100
346
8/26/2022
9/15/2021
Renewal
0012J00002QLRmAQAX
0012J00002QLRmAQAX
eTMF
Vault
R&D
0012J00002QLRmA
ASH Research Collaborative
139
8/28/2022
US Sales User - R&D SMB
Nick Robison
Christopher Mundy
Kodiak Sciences
Renewal 2022: Kodiak Sciences - QualityDocs - 200 ELA
Closed Won
Q3-2023
100
347
8/28/2022
9/15/2021
Renewal
0015000000bhNQvAAM
0015000000bhNQvAAM
QualityDocs
Vault
R&D
0015000000bhNQv
Kodiak Sciences
140
8/30/2022
US Sales User - R&D SMB
Krystal Kermott
Christopher Mundy
Lexicon Pharmaceuticals, Inc
Renewal 2022: Lexicon - Safety - 250 active cases
Closed Won
Q3-2023
100
350
8/30/2022
9/14/2021
Sales
Renewal
0015000000Lq8CgAAJ
0015000000Lq8CgAAJ
Vault Safety
Vault
R&D
0015000000Lq8Cg
Lexicon Pharmaceuticals, Inc.
141
8/30/2022
US Sales User - R&D SMB
David Moneuse
Phil Sager
Biocryst Pharmaceuticals, Inc.
Renewal 2022: Biocryst - Submissions & Submissions Archive - ELA400
Closed Won
Q3-2023
100
398
8/30/2022
7/28/2021
Renewal
0015000000Lq8AvAAJ
0015000000Lq8AvAAJ
Submissions; Submissions Archive
Vault
R&D
0015000000Lq8Av
Biocryst Pharmaceuticals, Inc.
142
8/30/2022
US Sales User - R&D SMB
David Moneuse
Phil Sager
Biocryst Pharmaceuticals, Inc.
Renewal 2022: Biocryst Pharmaceuticals - QMS & QualityDocs - ELA400
Closed Won
Q3-2023
100
398
8/30/2022
7/28/2021
Renewal
0015000000Lq8AvAAJ
0015000000Lq8AvAAJ
QualityDocs
Vault
R&D
0015000000Lq8Av
Biocryst Pharmaceuticals, Inc.
143
8/30/2022
US Sales User - R&D SMB
David Moneuse
Phil Sager
Spark Therapeutics, Inc.
Renewal 2022: Spark Platform Contracts Management
Closed Won
Q3-2023
100
368
8/30/2022
8/27/2021
Renewal
0015000000tq9LNAAY
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
Platform
Vault
R&D
0015000000tq9LN
0015000001nyFxK
Spark Therapeutics, Inc.
144
8/31/2022
EU Sales User - R&D ENT
Jürgen Grampp
Genentech, Inc.
Renewal - Roche Pharma eTMF/CTMS Y3 ramp (EU+US)
Closed Won
Q3-2023
100
1064
8/31/2022
10/2/2019
Sales
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
CTMS; eTMF
Vault
R&D
0015000000IO27U
0015000001nyFxK
Chugai Pharmaceutical Co.,Ltd.
145
9/2/2022
US Sales User - R&D SMB
Allie Grodin
Jim Thai
Calico Life Sciences LLC
Renewal 2022: Calico Life Sciences - QualityDocs + Training
Closed Won
Q3-2023
100
337
9/2/2022
10/1/2021
Renewal
0015000001nxYfoAAE
0015000001nxYfoAAE
QualityDocs
Vault
R&D
0015000001nxYfo
Calico Life Sciences LLC
146
9/2/2022
EU Sales User - R&D ENT
Julien Bechtel
UCB Biopharma SRL
Renewal 2022: UCB Zogenix Legacy eTMF - $0 OF For migration
Closed Won
Q3-2023
100
110
9/2/2022
5/16/2022
Sales
Subscription
00150000018OaEYAA0
0012J00002MJ2bHQAT
0012J00002MJ2bHQAT
0012J00002MJ2bHQAT
R&D
00150000018OaEY
0012J00002bzOpx
Zogenix, Inc.
147
9/5/2022
EU Sales User - R&D ENT
Fabian Metz
BIONTECH US INC.
Renewal 2022: BioNTech US - eTMF - migration courtesy access
Closed Won
Q3-2023
100
355
9/5/2022
9/15/2021
Renewal
0015000001HE1PXAA1
0015000001HENG5AAP
0015000001HENG5AAP
0015000001HENG5AAP
eTMF
Vault
R&D
0015000001HE1PX
0015000001HENG5
BIONTECH US INC.
148
9/6/2022
US Sales User - R&D SMB
Michelle Figueroa
Jim Thai
Xeris Pharmaceuticals, Inc.
Renewal 2022: Xeris - eTMF Renewal
Closed Won
Q3-2023
100
336
9/6/2022
10/5/2021
Renewal
00150000018Qz0AAAS
00150000018Qz0AAAS
eTMF
Vault
R&D
00150000018Qz0A
Strongbridge Biopharma plc
149
9/6/2022
EU Sales User - R&D ENT
Fabian Metz
BioNTech SE
BioNTech SE - eTMF, CTMS, SSU- ELA Year 2
Closed Won
Q3-2023
100
81
9/6/2022
6/17/2022
Sales
Subscription
0015000001HENG5AAP
0015000001HENG5AAP
R&D
0015000001HENG5
BIONTECH US INC.
150
9/6/2022
EU Sales User - R&D ENT
Fabian Metz
BioNTech SE
BioNTech SE - eTMF, CTMS, SSU- ELA Year 3
Closed Won
Q3-2023
100
81
9/6/2022
6/17/2022
Sales
Subscription
0015000001HENG5AAP
0015000001HENG5AAP
R&D
0015000001HENG5
BIONTECH US INC.
151
9/7/2022
US Sales User - R&D SMB
Kelly Morrison
Jonathan Waldvogel
Black Diamond Therapeutics, Inc.
Renewal 2022: Black Diamond Therapeutics_Vault eTMF
Closed Won
Q3-2023
100
342
9/7/2022
9/30/2021
Renewal
0015000002IiNnuAAF
0015000002IiNnuAAF
CTMS; eTMF; SiteConnect
Vault
R&D
0015000002IiNnu
Black Diamond Therapeutics
152
9/7/2022
US Sales User - R&D SMB
David Moneuse
Phil Sager
Spark Therapeutics, Inc.
Renewal 2022: Spark - Quality - QMS
Closed Won
Q3-2023
100
362
9/7/2022
9/10/2021
Renewal
0015000000tq9LNAAY
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
QMS
Vault
R&D
0015000000tq9LN
0015000001nyFxK
Spark Therapeutics, Inc.
153
9/8/2022
EU Sales User - R&D SMB
Katrine Bødker Christensen
Calliditas Therapeutics AB
Renewal 2022: Calliditas Therapeutics AB - QD ELA 200 Subs
Closed Won
Q3-2023
100
343
9/8/2022
10/1/2021
Renewal
0015000002GUdjmAAD
0015000002GUdjmAAD
Submissions
Vault
R&D
0015000002GUdjm
Calliditas Therapeutics
154
9/12/2022
US Sales User - R&D SMB
Anthony Henry
Phil Sager
Immunocore, Ltd
Renewal 2022: Immunocore - Vault RIM
Closed Won
Q3-2023
100
139
9/12/2022
4/26/2022
Sales
Subscription
0012J00002LO4EvQAL
0012J00002LO4EvQAL
R&D
0012J00002LO4Ev
Immunocore, Ltd
155
9/13/2022
US Sales User - CRO
Joey Sineno
Katie Tipton
St. Jude Children's Research Hospital, Inc.
Renewal 2022: St Jude CRH Clinical Apps
Closed Won
Q3-2023
100
397
9/13/2022
8/12/2021
Renewal
00150000014RszdAAC
00150000014RszdAAC
eTMF
Vault
R&D
00150000014Rszd
St. Jude Children's Research Hospital
156
9/14/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Allucent
Renewal May 2023: Allucent - Clinical Suite Study ELA 200
Closed Won
Q3-2023
100
0
9/14/2022
9/14/2022
Sales
Subscription
0015000000htJv3AAE
0015000000htJv3AAE
R&D
0015000000htJv3
Pharm-Olam International, LLC
157
9/14/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Allucent
Renewal May 2024: Allucent - Clinical Suite Study ELA 200
Closed Won
Q3-2023
100
0
9/14/2022
9/14/2022
Sales
Subscription
0015000000htJv3AAE
0015000000htJv3AAE
R&D
0015000000htJv3
Pharm-Olam International, LLC
158
9/16/2022
EU Sales User - R&D ENT
Julien Bechtel
Ferring International Center SA
Ferring - QualityDocs ELA Year 2 Renewal + Ramp
Closed Won
Q3-2023
100
406
9/16/2022
8/6/2021
Sales
Subscription
0015000000aQAuPAAW
0012J00002MKF7XQAX
0012J00002MKF7XQAX
0012J00002MKF7XQAX
QMS; QualityDocs
Vault
R&D
0015000000aQAuP
0012J00002MKF7X
FerGene
159
9/16/2022
US Sales User - R&D SMB
Justin Zaccone
Ernie Chin
Sumitomo Pharma Oncology, Inc.
Renewal 2022: SDPO- eTMF & Platform Renewal
Closed Won
Q3-2023
100
367
9/16/2022
9/15/2021
Renewal
0015000000ph6mWAAQ
0012J00002MKw1cQAD
0012J00002MKw1cQAD
0012J00002MKw1cQAD
eTMF
Vault
R&D
0015000000ph6mW
0012J00002MKw2r
SUMITOMO DAINIPPON PHARMA CO., LTD.
160
9/19/2022
US Sales User - R&D SMB
David Moneuse
Phil Sager
Spark Therapeutics, Inc.
Renewal 2022: Spark - NA - eTMF/CTMS Sites - ELA
Closed Won
Q3-2023
100
374
9/19/2022
9/10/2021
Renewal
0015000000tq9LNAAY
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
CTMS; eTMF
Vault
R&D
0015000000tq9LN
0015000001nyFxK
Spark Therapeutics, Inc.
161
9/20/2022
US Sales User - R&D SMB
Kelly Morrison
Jonathan Waldvogel
FerGene Inc.
Renewal Oct 2022: FerGene- Qdocs, Training, QMS, Subs & SubA #NC
Closed Won
Q3-2023
100
173
9/20/2022
3/31/2022
Subscription
0012J00002OdrDNQAZ
0012J00002MKF7XQAX
0012J00002MKF7XQAX
0012J00002MKF7XQAX
R&D
0012J00002OdrDN
0012J00002MKF7X
FerGene
162
9/21/2022
US Sales User - R&D SMB
Mary Molnar
Phil Sager
Myovant Sciences, Inc.
Renewal 2022: Myovant Sciences (SV) - Vault eTMF - 25 Active Sites
Closed Won
Q3-2023
100
348
9/21/2022
10/8/2021
Renewal
0015000001OFSfGAAX
0012J00002MKw1cQAD
0012J00002MKw1cQAD
0012J00002MKw1cQAD
eTMF
Vault
R&D
0015000001OFSfG
0012J00002OfD5X
SUMITOMO DAINIPPON PHARMA CO., LTD.
163
9/22/2022
US Sales User - R&D SMB
Jinna Penachio
Jonathan Waldvogel
HilleVax, Inc.
Renewal 2022: HilleVax eTMF Archive
Closed Won
Q3-2023
100
358
9/22/2022
9/29/2021
Renewal
0012J00002U6WwuQAF
0012J00002U6WwuQAF
eTMF
Vault
R&D
0012J00002U6Wwu
HilleVax
164
9/22/2022
US Sales User - R&D SMB
Krystal Kermott
Christopher Mundy
Polynoma LLC
Renewal 2022: Polynoma - Vault eTMF - 75 Active to Archive Sites
Closed Won
Q3-2023
100
118
9/22/2022
5/27/2022
Sales
Subscription
0015000000fTTJBAA4
0015000000fTTJBAA4
R&D
0015000000fTTJB
Polynoma LLC
165
9/26/2022
US Sales User - CRO
Joel Evans
InVentiv Health Clinical, LLC, a subsidiary of Syneos Health Inc
Renewal Oct 2023: Syneos - Unified Clinical - SSU, CTMS, Payments - YR2
Closed Won
Q3-2023
100
0
9/26/2022
9/26/2022
Sales
Subscription
0012J00002KlvT8QAJ
0012J00002MKPWbQAP
0012J00002MKPWbQAP
0012J00002MKPWbQAP
R&D
0012J00002KlvT8
0012J00002MKPWb
Inventiv
166
9/26/2022
US Sales User - CRO
Joel Evans
InVentiv Health Clinical, LLC, a subsidiary of Syneos Health Inc
Renewal Oct 2024: Syneos - Unified Clinical - SSU, CTMS, Payments - YR3
Closed Won
Q3-2023
100
0
9/26/2022
9/26/2022
Sales
Subscription
0012J00002KlvT8QAJ
0012J00002MKPWbQAP
0012J00002MKPWbQAP
0012J00002MKPWbQAP
R&D
0012J00002KlvT8
0012J00002MKPWb
Inventiv
167
9/26/2022
CN Sales User - R&D ENT
Stephanie Zhang
TAIZHOU EOC pharma Co.,ltd
Renewal Sep 2023: EOCPharma-China-Submission&Sub Archive-15users&2users
Closed Won
Q3-2023
100
0
9/26/2022
9/26/2022
Sales
Subscription
0012J00002aZ3sPQAS
0015000000tsIxGAAU
0015000000tsIxGAAU
0015000000tsIxGAAU
R&D
0012J00002aZ3sP
0015000000tsIxG
Ceclor
168
9/26/2022
CN Sales User - R&D ENT
Stephanie Zhang
TAIZHOU EOC pharma Co.,ltd
Renewal Sep 2024: EOCPharma-China-Submission&Sub Archive-15users&2users
Closed Won
Q3-2023
100
0
9/26/2022
9/26/2022
Sales
Subscription
0012J00002aZ3sPQAS
0015000000tsIxGAAU
0015000000tsIxGAAU
0015000000tsIxGAAU
R&D
0012J00002aZ3sP
0015000000tsIxG
Ceclor
169
9/28/2022
US Sales User - R&D SMB
Kelly Morrison
Jonathan Waldvogel
Black Diamond Therapeutics, Inc.
Renewal 2022: Black Diamond_Vault RIM (Submissions/Publishing/Submissions Archive) #NC
Closed Won
Q3-2023
100
364
9/28/2022
9/29/2021
Renewal
0015000002IiNnuAAF
0015000002IiNnuAAF
Submissions; Submissions Archive
Vault
R&D
0015000002IiNnu
Black Diamond Therapeutics
170
9/28/2022
US Sales User - R&D SMB
Allie Grodin
Jim Thai
Calico Life Sciences LLC
Renewal 2022: Calico Life Sciences - Vault Sub/SubA - 10 Subs; 5 SubsA Users
Closed Won
Q3-2023
100
142
9/28/2022
5/9/2022
Sales
Subscription
0015000001nxYfoAAE
0015000001nxYfoAAE
R&D
0015000001nxYfo
Calico Life Sciences LLC
171
9/28/2022
US Sales User - R&D ENT
Jon Tenconi
Astellas Pharma US LLC
Renewal 2022: Astellas - Issue Management - Active Study License
Closed Won
Q3-2023
100
377
9/28/2022
9/16/2021
Renewal
0015000000IO270AAD
0012J00002N44FaQAJ
0012J00002N44FaQAJ
0012J00002N44FaQAJ
CTMS
Vault
R&D
0015000000IO270
0012J00002bzHrs
Audentes Therapeutics, Inc.
172
9/29/2022
US Sales User - R&D SMB
Michelle Figueroa
Jim Thai
Xeris Pharmaceuticals, Inc.
Renewal 2022: Xeris - Submissions and Submissions Archive Renewal
Closed Won
Q3-2023
100
364
9/29/2022
10/1/2021
Renewal
00150000018Qz0AAAS
00150000018Qz0AAAS
QualityDocs
Vault
R&D
00150000018Qz0A
Strongbridge Biopharma plc
173
9/29/2022
US Sales User - R&D SMB
Nick Robison
Christopher Mundy
Adverum Biotechnologies, Inc.
Renewal 2022: Adverum Biotechnologies - Vault Sub/SubA - 200 ELA
Closed Won
Q3-2023
100
364
9/29/2022
10/1/2021
Renewal
0015000000wO1vGAAS
0015000000wO1vGAAS
Submissions; Submissions Archive
Vault
R&D
0015000000wO1vG
Adverum Biotechnologies, Inc.
174
9/29/2022
US Sales User - R&D SMB
Allie Grodin
Jim Thai
Calico Life Sciences LLC
Renewal 2022: Calico Life Sciences - CTMS - 40 active, 1 archive, 34 future active
Closed Won
Q3-2023
100
364
9/29/2022
10/1/2021
Renewal
0015000001nxYfoAAE
0015000001nxYfoAAE
eTMF
Vault
R&D
0015000001nxYfo
Calico Life Sciences LLC
175
9/29/2022
US Sales User - R&D SMB
Will Gould
Jonathan Waldvogel
Seres Therapeutics, Inc.
Renewal 2022: Seres Therapeutics-Vault RIM, Clinical, & Quality
Closed Won
Q3-2023
100
363
9/29/2022
10/1/2021
Renewal
0015000000zPfrZAAS
0015000000zPfrZAAS
QualityDocs; Submissions; Submissions Archive
Vault
R&D
0015000000zPfrZ
Seres Therapeutics, Inc.
176
9/29/2022
US Sales User - CRO
Joey Sineno
Katie Tipton
Social & Scientific Systems, Inc.
Renewal Oct 2022: S3 DMID-BET - Consolidated 61 Sites
Closed Won
Q3-2023
100
80
9/29/2022
7/11/2022
Subscription
0015000000tQUB1AAO
0015000000tQUB1AAO
R&D
0015000000tQUB1
Social & Scientific Systems, Inc.
177
9/30/2022
US Sales User - R&D SMB
Michelle Figueroa
Jim Thai
Xeris Pharmaceuticals, Inc.
Renewal 2022: Xeris - Vault Quality Renewal
Closed Won
Q3-2023
100
365
9/30/2022
10/1/2021
Renewal
00150000018Qz0AAAS
00150000018Qz0AAAS
QualityDocs
Vault
R&D
00150000018Qz0A
Strongbridge Biopharma plc
178
9/30/2022
US Sales User - R&D SMB
Anthony Henry
Phil Sager
Immunocore, Ltd
Renewal 2022: Immunocore - Clinical
Closed Won
Q3-2023
100
262
9/30/2022
1/11/2022
Sales
Subscription
0012J00002LO4EvQAL
0012J00002LO4EvQAL
R&D
0012J00002LO4Ev
Immunocore, Ltd
179
9/30/2022
EU Sales User - R&D SMB
Charlie Williams
MeiraGTx LLC
Renewal 2022: Meira GTX (New Logo) - eTMF 20 Sites
Closed Won
Q3-2023
100
360
9/30/2022
10/5/2021
Renewal
0012J00002XRL5vQAH
0012J00002XRL5vQAH
eTMF
Vault
R&D
0012J00002XRL5v
MeiraGTx LLC
180
10/7/2022
US Sales User - MedTech ENT
David Duffy
Becton Dickinson
BD - CTMS & Payments Period 3 Renewal/Superseding final year, eTMF ELA Conversion
6. Awaiting P.O.
Q3-2023
99
847
10/7/2022
6/12/2020
Strategy Team
Subscription
0012J00002MKF7IQAX
0012J00002MKF7IQAX
CTMS
Vault
R&D
0012J00002MKF7I
Becton, Dickinson and Company
181
10/12/2022
EU Sales User - R&D SMB
Davide Pesenti
EUSA Pharma (UK) Ltd
Recordati EUSA Migration 35 sites renewal 3 months
6. Awaiting P.O.
Q3-2023
99
46
10/12/2022
8/22/2022
Subscription
00150000018O5POAA0
0015000000VSdDeAAL
0015000000VSdDeAAL
0015000000VSdDeAAL
R&D
00150000018O5PO
0015000000VSdDe
EUSA Pharma
182
10/14/2022
US Sales User - R&D SMB
Jinna Penachio
Jonathan Waldvogel
Surface Oncology Inc.
Renewal 2022: Surface Oncology: Vault Quality Docs & Training
6. Awaiting P.O.
Q3-2023
99
350
10/14/2022
10/22/2021
Sales
Subscription
00150000018PrBDAA0
00150000018PrBDAA0
R&D
00150000018PrBD
Surface Oncology, Inc
183
10/14/2022
US Sales User - R&D SMB
Mary Molnar
Phil Sager
Roivant Sciences, Inc.
Renewal 2022: Roivant Sciences - LearnGxP
4. Negotiation
Q3-2023
90
277
10/14/2022
1/3/2022
Sales
Subscription
0015000001APsQwAAL
0015000001APsQwAAL
R&D
0015000001APsQw
Dermavant Sciences
184
10/14/2022
EU Sales User - R&D SMB
Charlie Williams
MeiraGTx LLC
Renewal 2022 Nov: MeiraGTx (New App) RIM - (Submissions, Archive 10 users)
5. Contracting
Q3-2023
99
37
10/14/2022
8/31/2022
Marketing
Subscription
0012J00002XRL5vQAH
0012J00002XRL5vQAH
R&D
0012J00002XRL5v
MeiraGTx LLC
185
10/15/2022
US Sales User - R&D SMB
David Hockenberry
Adam De Oliveira
Ocugen, Inc.
Renewal 2022: Ocugen - QDocs & Training
4. Negotiation
Q3-2023
99
37
10/15/2022
8/31/2022
Sales Support
Subscription
0015000000tFn6fAAC
0015000000tFn6fAAC
R&D
0015000000tFn6f
Ocugen, Inc.
186
10/15/2022
EU Sales User - R&D SMB
Marco Macioszek
RICHTER-HELM BIOLOGICS GMBH & CO. KG
Renewal 2022: Richter-Helm - EU - QMS
6. Awaiting P.O.
Q3-2023
99
308
10/15/2022
12/3/2021
Sales
Subscription
0015000000ePgYjAAK
0015000000ePgYjAAK
R&D
0015000000ePgYj
RICHTER-HELM BIOLOGICS GMBH & CO. KG
187
10/17/2022
EU Sales User - R&D ENT
Jürgen Grampp
Genentech, Inc.
Roche Pharma - QD (EU+US) - Yr 3 renewal
Closed Won
Q3-2023
100
739
10/17/2022
10/8/2020
Sales
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
QualityDocs
Vault
R&D
0015000000IO27U
0015000001nyFxK
Chugai Pharmaceutical Co.,Ltd.
188
10/20/2022
US Sales User - R&D SMB
Seth Fox
David Florez
Amneal Pharmaceuticals LLC
Renewal 2022: Amneal - QualityDocs
5. Contracting
Q3-2023
99
133
10/20/2022
5/27/2022
Sales
Subscription
0015000000LVRnaAAH
0012J00002MKhD2QAL
0012J00002MKhD2QAL
0012J00002MKhD2QAL
R&D
0015000000LVRna
0012J00002MKhD2
Impax Laboratories, Inc.
189
10/21/2022
US Sales User - R&D SMB
Abbe Macbeth
Phil Sager
Supernus Pharmaceuticals, Inc.
Renewal 2022: Supernus Pharmaceuticals-QDocs, Training & QMS
4. Negotiation
Q3-2023
90
372
10/21/2022
10/1/2021
Renewal
0015000000PiLnMAAV
0015000000PiLnMAAV
QMS; QualityDocs
Vault
R&D
0015000000PiLnM
Supernus Pharmaceuticals, Inc.
190
10/21/2022
US Manager - R&D Sales
Christopher Mundy
Christopher Mundy
Shattuck Labs, Inc.
Renewal 2022: Shattuck Labs - 100 ELAVault Submissions and 8 Submissions Archive
4. Negotiation
Q3-2023
95
351
10/21/2022
10/21/2021
Other
Subscription
0012J00002QJUllQAH
0012J00002QJUllQAH
R&D
0012J00002QJUll
Shattuck Labs, Inc.
191
10/21/2022
US Sales User - CRO
Joey Sineno
Katie Tipton
St. Jude Children's Research Hospital, Inc.
Renewal 2022: St Jude CRH - SiteConnect
5. Contracting
Q3-2023
99
236
10/21/2022
2/13/2022
Sales
Subscription
00150000014RszdAAC
00150000014RszdAAC
R&D
00150000014Rszd
St. Jude Children's Research Hospital
192
10/21/2022
EU Sales User - R&D ENT
Zoltan Szarka
GSK
Renewal 2022: GSK Vault Platform Health Outcome Tracker
3. Proposal
Q3-2023
90
343
10/21/2022
10/29/2021
Sales
Subscription
0012J00002LPpFrQAL
0012J00002LPpFrQAL
R&D
0012J00002LPpFr
Tesaro, Inc.
193
10/21/2022
EU Sales User - R&D SMB
Katrine Bødker Christensen
Oncopeptides AB
Renewal 2022: Oncopeptides- QD, RIM
4. Negotiation
Q3-2023
99
246
10/21/2022
2/3/2022
Sales
Subscription
0015000001RQkXdAAL
0015000001RQkXdAAL
R&D
0015000001RQkXd
Oncopeptides AB
194
10/25/2022
LatAm Sales User
Luis Fernandez
Laboratorios Sophia, S.A. de C.V.
Renewal 2022: Sophia Mexico eTMF total: 25 Active sites + 1 Archive site
2. Discovery
Q3-2023
30
347
10/25/2022
10/25/2021
Sales
Subscription
0012J00002LPqbwQAD
0012J00002LPqbwQAD
R&D
0012J00002LPqbw
Laboratorios Sophia
195
10/27/2022
CN Sales User - R&D ENT
Stephanie Zhang
Suzhou Ceclor Pharmaceutical Co., Ltd.
Renewal 2022: Ceclor-China-QMS-biotech ELA250
5. Contracting
Q3-2023
99
345
10/27/2022
10/27/2021
Strategy Team
Subscription
0012J00002U7d2UQAR
0015000000tsIxGAAU
0015000000tsIxGAAU
0015000000tsIxGAAU
R&D
0012J00002U7d2U
0015000000tsIxG
Ceclor
196
10/31/2022
US Sales User - R&D SMB
Krystal Kermott
Christopher Mundy
Lexicon Pharmaceuticals, Inc
Renewal 2022: Lexicon Submissions, Submissions Archive and Publishing
4. Negotiation
Q3-2023
95
319
10/31/2022
11/22/2021
Sales
Subscription
0015000000Lq8CgAAJ
0015000000Lq8CgAAJ
R&D
0015000000Lq8Cg
Lexicon Pharmaceuticals, Inc.
197
10/31/2022
US Sales User - R&D SMB
Will Gould
Jonathan Waldvogel
Intarcia Therapeutics, Inc.
Renewal 2022: Intarcia Therapeutics_Veeva QualityDocs Superseding Licensing Extension October 2022
4. Negotiation
Q3-2023
95
178
10/31/2022
4/12/2022
Subscription
0015000001IfBXpAAN
0015000001IfBXpAAN
R&D
0015000001IfBXp
Intarcia Therapeutics, Inc.
198
10/31/2022
JP Sales User - R&D ENT
Junichiro Tomoda
ASAHI KASEI PHARMA CORPORATION
Renewal 2022: Asahikasei Pharma eTMF 32sites - Japan Local Deal
4. Negotiation
Q3-2023
90
302
10/31/2022
12/9/2021
Sales
Subscription
0015000000ORqreAAD
0015000000ORqreAAD
R&D
0015000000ORqre
Asahi Kasei Pharma
199
10/31/2022
EU Sales User - CDMS
Sam Rolfe
Exom Group Srl
Renewal Dec 2022: Exom - eTMF - 162 sites - dec -feb 3 months
4. Negotiation
Q3-2023
95
77
10/31/2022
7/22/2022
Sales
Subscription
0015000000tptQnAAI
0015000000tptQnAAI
R&D
0015000000tptQn
Exom Group
200
11/1/2022
US Sales User - R&D SMB
Will Farley
Adam De Oliveira
Sanaria
Renewal 2022: Sanaria_Veeva Vault eTMF Renewal
2. Discovery
Q4-2023
0
358
11/1/2022
10/14/2021
Renewal
0015000000mNPPqAAO
0015000000mNPPqAAO
eTMF
Vault
R&D
0015000000mNPPq
Sanaria, Inc.
201
11/1/2022
US Sales User - R&D SMB
Will Farley
Adam De Oliveira
Dova Pharmaceuticals, Inc.
Renewal 2022: Dova RIM short term
4. Negotiation
Q4-2023
95
340
11/1/2022
11/1/2021
Sales
Subscription
0015000001Niyx9AAB
0015000000OU1qNAAT
0015000000OU1qNAAT
0015000000OU1qNAAT
R&D
0015000001Niyx9
0015000000OU1qN
Dova Pharmaceuticals, LLC
202
11/1/2022
US Sales User - R&D SMB
Hillary Hornbeck
Ernie Chin
Jazz Pharmaceuticals, Inc.
Renewal 2023: Jazz Pharmaceuticals - New Vault - RIM
5. Contracting
Q4-2023
98
267
11/1/2022
1/13/2022
Sales
Subscription
0015000000IO27gAAD
0012J00002MKw19QAD
0012J00002MKw19QAD
0012J00002MKw19QAD
R&D
0015000000IO27g
0012J00002bzPP2
Jazz Pharmaceuticals, Inc.
203
11/3/2022
CN Sales User - R&D SMB
Shirley Wang
Mabspace Biosciences (Suzhou) Co. LTd.
Renewal 2022: Mabspacebio-China-QualityDocs-China Biotech ELA 250
4. Negotiation
Q4-2023
95
338
11/3/2022
11/3/2021
Sales
Subscription
0012J00002Qdd40QAB
0012J00002PxlbbQAB
0012J00002PxlbbQAB
0012J00002PxlbbQAB
R&D
0012J00002Qdd40
0012J00002Pxlbb
Suzhou Transcenta Therapeutics Co., Ltd.
204
11/4/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Atlantic Research Group, Inc.
Renewal Dec 2022: Atlantic Research Group - CTMS
4. Negotiation
Q4-2023
95
46
11/4/2022
8/22/2022
Sales
Subscription
0015000000qIWUEAA4
0015000000qIWUEAA4
R&D
0015000000qIWUE
Atlantic Research Group, Inc.
205
11/4/2022
US Sales User - CDMS
Amy Pickle
Katie Tipton
Atlantic Research Group, Inc.
Renewal Dec 2022: Atlantic Research Group eTMF Full Account Renewal 12/1/2022
4. Negotiation
Q4-2023
95
46
11/4/2022
8/22/2022
Subscription
0015000000qIWUEAA4
0015000000qIWUEAA4
R&D
0015000000qIWUE
Atlantic Research Group, Inc.
206
11/5/2022
US Sales User - R&D SMB
Jinna Penachio
Jonathan Waldvogel
HilleVax, Inc.
Renewal Dec 2022: HilleVax Submissions and Subs A
5. Contracting
Q4-2023
99
127
11/5/2022
6/2/2022
Sales
Subscription
0012J00002U6WwuQAF
0012J00002U6WwuQAF
R&D
0012J00002U6Wwu
HilleVax
207
11/10/2022
CN Sales User - R&D ENT
Stephanie Zhang
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Renewal 2022 Dizal-China-eTMF-China Biotech ELA 250
Closed Won
Q4-2023
100
716
11/10/2022
11/24/2020
Renewal
0012J00002RDkCgQAL
0012J00002QK82jQAD
0012J00002QK82jQAD
0012J00002QK82jQAD
eTMF
Vault
R&D
0012J00002RDkCg
0012J00002QK82j
Dizal Pharmaceutical
208
11/11/2022
US Sales User - CRO
Joey Sineno
Katie Tipton
Social & Scientific Systems, Inc.
Renewal Dec 2022: S3 DMID-BET - Consolidated 61 Sites
4. Negotiation
Q4-2023
95
8
11/11/2022
9/29/2022
Subscription
0015000000tQUB1AAO
0015000000tQUB1AAO
R&D
0015000000tQUB1
Social & Scientific Systems, Inc.
209
11/15/2022
US Sales User - CRO
Greyson McGrail
Katie Tipton
Technical Resources International, Inc.
Renewal 2022: TRI Vault Subs/Subs A - CCR Vault
4. Negotiation
Q4-2023
99
400
11/15/2022
9/2/2021
Renewal
0015000000olZKlAAM
0015000000olZKlAAM
Submissions; Submissions Archive
Vault
R&D
0015000000olZKl
Technical Resources International, Inc.
210
11/15/2022
US Sales User - R&D SMB
Mariah Lewis
Jim Thai
Turning Point Therapeutics, Inc.
Renewal 2022: Turning Point Therapeutics - Submissions and Submissions Archive
4. Negotiation
Q4-2023
80
175
11/15/2022
4/15/2022
Subscription
0015000001eME6lAAG
0015000001eME6lAAG
R&D
0015000001eME6l
Turning Point Therapeutics, Inc.
211
11/15/2022
US Sales User - CRO
Greyson McGrail
Katie Tipton
Technical Resources International, Inc.
Renewal Dec 2022: TRI eTMF 12-1-2022
4. Negotiation
Q4-2023
95
128
11/15/2022
6/1/2022
Subscription
0015000000olZKlAAM
0015000000olZKlAAM
R&D
0015000000olZKl
Technical Resources International, Inc.
212
11/16/2022
US Sales User - R&D SMB
Caroline Barry
Jonathan Waldvogel
Spero Therapeutics, Inc.
Renewal 2022: Spero Therapeutics- QD, VT and QMS ELA 100
5. Contracting
Q4-2023
99
322
11/16/2022
11/19/2021
Sales
Subscription
0015000001ODHG9AAP
0015000001ODHG9AAP
R&D
0015000001ODHG9
Spero Therapeutics, Inc.
213
11/16/2022
US Sales User - R&D SMB
Caroline Barry
Jonathan Waldvogel
Spero Therapeutics, Inc.
Renewal 2022: Spero Therapeutics- RIM ELA
5. Contracting
Q4-2023
99
310
11/16/2022
12/1/2021
Sales
Subscription
0015000001ODHG9AAP
0015000001ODHG9AAP
R&D
0015000001ODHG9
Spero Therapeutics, Inc.
214
11/17/2022
US Manager - R&D Sales
Christopher Mundy
Christopher Mundy
La Jolla Pharmaceutical Company
Renewal 2022: La Jolla Pharmaceutical Company ? Submissions-eTMF-QualityDocs
4. Negotiation
Q4-2023
95
324
11/17/2022
11/17/2021
Sales
Subscription
0015000000Lq8CdAAJ
0015000000Lq8CdAAJ
R&D
0015000000Lq8Cd
La Jolla Pharmaceutical Company
215
11/18/2022
EU Sales User - MedTech ENT
Eleni Tragousti
Institut Straumann AG
Renewal 2022: Straumann - Vault QMS - period 1 - 8
Closed Won
Q4-2023
100
403
11/18/2022
10/11/2021
Sales
Subscription
0012J00002U5C7vQAF
0012J00002U5C7vQAF
QMS
Vault
R&D
0012J00002U5C7v
Straumann Usa, LLC
216
11/23/2022
EU Sales User - R&D SMB
Hasse Rando
Swedish Orphan Biovitrum AB (publ)
Renewal 2023: SOBI RIM
4. Negotiation
Q4-2023
95
318
11/23/2022
11/23/2021
Sales
Subscription
0015000000OU1qNAAT
0015000000OU1qNAAT
R&D
0015000000OU1qN
Dova Pharmaceuticals, LLC
217
11/24/2022
US Sales User - R&D SMB
Mariah Lewis
Jim Thai
Arcturus Therapeutics, Inc.
Renewal 2022: Arcturus Therapeutics - Vault eTMF - 19 eTMF Active Sites & 2 Archive Sites
3. Proposal
Q4-2023
70
317
11/24/2022
11/24/2021
Sales
Subscription
0015000000r8H7sAAE
0015000000r8H7sAAE
R&D
0015000000r8H7s
Arcturus Therapeutics, Inc.
218
11/30/2022
US Sales User - R&D SMB
Jonathan Benzimra
Adam De Oliveira
Acorda Therapeutics, Inc.
Renewal 2022: Acorda Therapeutics - Quality & eTMF
4. Negotiation
Q4-2023
99
64
11/30/2022
8/4/2022
Subscription
0015000000IO26iAAD
0015000000IO26iAAD
R&D
0015000000IO26i
Acorda Therapeutics, Inc.
219
11/30/2022
EU Sales User - R&D SMB
Rachel Rees
GlaxoSmithKline LLC
Renewal 2023 Jan: GSK Pharma Vault QMS P3
6. Awaiting P.O.
Q4-2023
99
687
11/30/2022
11/19/2020
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
QMS
Vault
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
220
11/30/2022
EU Sales User - R&D SMB
Rachel Rees
GlaxoSmithKline LLC
Renewal: GSK Consumer Safety 2023
6. Awaiting P.O.
Q4-2023
99
666
11/30/2022
12/10/2020
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
Vault Safety
Vault
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
221
11/30/2022
EU Sales User - R&D SMB
Davide Pesenti
Recordati Rare Diseases, Inc.
Renewal Dec 2022: Recordati US- Vault Training - 153 users
4. Negotiation
Q4-2023
95
70
11/30/2022
7/29/2022
Subscription
0015000000pJSINAA4
0015000000VSdDeAAL
0015000000VSdDeAAL
0015000000VSdDeAAL
R&D
0015000000pJSIN
0015000000VSdDe
Recordati Rare Diseases, Inc.
222
12/1/2022
US Sales User - R&D SMB
Kerri Klidas
Jim Thai
Vaxart, Inc.
Renewal 2023: Vaxart - Vault Sub/SubA - 50 ELA + 5 Archive Users
4. Negotiation
Q4-2023
90
399
12/1/2022
9/3/2021
Renewal
0015000001HesyBAAR
0015000001HesyBAAR
Submissions; Submissions Archive
Vault
R&D
0015000001HesyB
Vaxart Inc
223
12/1/2022
US Sales User - R&D SMB
David Hockenberry
Adam De Oliveira
ADC Therapeutics SA
Renewal 2022: ADC Therapeutics - (New Logo) - Submissions Archive
4. Negotiation
Q4-2023
95
352
12/1/2022
10/20/2021
Sales
Subscription
0015000001CrmGfAAJ
0015000001HhQaiAAF
0015000001HhQaiAAF
0015000001HhQaiAAF
R&D
0015000001CrmGf
0015000001HhQai
ADC Therapeutics
224
12/1/2022
US Sales User - R&D SMB
Kerri Klidas
Jim Thai
Vaxart, Inc.
Renewal 2023 Jan: Vaxart - Vault QualityDocs/Training - 200 ELA
4. Negotiation
Q4-2023
90
340
12/1/2022
11/1/2021
Sales
Subscription
0015000001HesyBAAR
0015000001HesyBAAR
R&D
0015000001HesyB
Vaxart Inc
225
12/1/2022
US Sales User - R&D SMB
Jonathan Benzimra
Adam De Oliveira
Iterum Therapeutics International Limited
Renewal 2023: Iterum Therapeutics_Vault eTMF and RIM
4. Negotiation
Q4-2023
95
326
12/1/2022
11/15/2021
Subscription
00150000014TbQlAAK
00150000014TbQlAAK
R&D
00150000014TbQl
Iterum Therapeutics International Limited
226
12/1/2022
US Sales User - R&D SMB
Kerri Klidas
Jim Thai
Vaxart, Inc.
Renewal 2022: Vaxart Inc - eTMF - 6 Active Sites, 10 Archive Sites, 26 add-on active sites
4. Negotiation
Q4-2023
90
296
12/1/2022
12/15/2021
Subscription
0015000001HesyBAAR
0015000001HesyBAAR
R&D
0015000001HesyB
Vaxart Inc
227
12/1/2022
US Sales User - R&D SMB
Kerri Klidas
Jim Thai
Rigel Pharmaceuticals, Inc.
Renewal 2022: Rigel - QD:37 Full Users, 55 RO Users - VT: 4 Admin Users, 88 Learner Users
4. Negotiation
Q4-2023
90
291
12/1/2022
12/20/2021
Subscription
0015000000NCeXCAA1
0015000000NCeXCAA1
R&D
0015000000NCeXC
Rigel Pharmaceuticals, Inc.
228
12/1/2022
US Sales User - R&D SMB
Kerri Klidas
Jim Thai
Rigel Pharmaceuticals, Inc.
Renewal 2022: Rigel - eTMF - 223 Active Sites
4. Negotiation
Q4-2023
90
291
12/1/2022
12/20/2021
Sales
Subscription
0015000000NCeXCAA1
0015000000NCeXCAA1
R&D
0015000000NCeXC
Rigel Pharmaceuticals, Inc.
229
12/1/2022
US Sales User - R&D SMB
Jonathan Benzimra
Adam De Oliveira
Neurogene
Renewal 2023: Neurogene_Vault Quality Suite (QualityDocs, Training, QMS)
4. Negotiation
Q4-2023
95
221
12/1/2022
2/28/2022
Subscription
0012J00002IlRrWQAV
0012J00002IlRrWQAV
R&D
0012J00002IlRrW
Neurogene
230
12/1/2022
US Sales User - R&D SMB
David Hockenberry
Adam De Oliveira
Idera Pharmaceuticals, Inc.
Renewal 2022: Idera - Submissions
4. Negotiation
Q4-2023
95
219
12/1/2022
3/2/2022
Sales
Subscription
0015000000MoUgQAAV
0015000000MoUgQAAV
R&D
0015000000MoUgQ
Idera Pharmaceuticals, Inc.
231
12/1/2022
US Sales User - R&D SMB
Kelly Morrison
Jonathan Waldvogel
Cullinan Oncology
Renewal 2023: Cullinan Oncology - Quality Docs/Training
4. Negotiation
Q4-2023
95
203
12/1/2022
3/18/2022
Subscription
0012J00002N4H28QAF
0012J00002N4H28QAF
R&D
0012J00002N4H28
Cullinan Oncology
232
12/1/2022
US Sales User - R&D SMB
Kelly Morrison
Jonathan Waldvogel
Cullinan Oncology
Renewal 2023: Cullinan Oncology - eTMF - (32)
3. Proposal
Q4-2023
40
163
12/1/2022
4/27/2022
Subscription
0012J00002N4H28QAF
0012J00002N4H28QAF
R&D
0012J00002N4H28
Cullinan Oncology
233
12/1/2022
US Sales User - R&D SMB
Michelle Figueroa
Jim Thai
Sention Therapeutics, LLC
Renewal 2023: Sention Therapeutics - RIM, Quality, & Clinical
5. Contracting
Q4-2023
95
161
12/1/2022
4/29/2022
Sales
Subscription
0012J00002XV4NEQA1
0012J00002XV4NEQA1
R&D
0012J00002XV4NE
Sention Therapeutics
234
12/1/2022
US Sales User - R&D SMB
Michelle Figueroa
Jim Thai
Intercept Pharmaceuticals, Inc.
Renewal 2023: Intercept - Vault eTMF - 25 Active Sites
5. Contracting
Q4-2023
95
151
12/1/2022
5/9/2022
Sales
Subscription
0015000000iRqSVAA0
0015000000iRqSVAA0
R&D
0015000000iRqSV
Intercept Pharmaceuticals, Inc.
235
12/1/2022
EU Sales User - R&D ENT
Zoltan Szarka
GlaxoSmithKline LLC
Renewal 2023: GSK | SSU 2022
5. Contracting
Q4-2023
99
1099
12/1/2022
10/4/2019
Renewal
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
Study Startup
Vault
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
236
12/1/2022
EU Sales User - R&D SMB
Reto Flury
Ferring Pharmaceuticals A/S
Renewal 2023: Ferring - Vault CTMS/SSU/Payments
5. Contracting
Q4-2023
98
331
12/1/2022
11/10/2021
Subscription
0012J00002N5k6lQAB
0012J00002MKF7XQAX
0012J00002MKF7XQAX
0012J00002MKF7XQAX
R&D
0012J00002N5k6l
0012J00002MKF7X
FerGene
237
12/1/2022
US Sales User - Safety
Michael Heimann
SCTbio a.s.
Renewal 2022: SOTIO A.S. - QDocs ELA 100 + QMS ELA 100
4. Negotiation
Q4-2023
95
310
12/1/2022
12/1/2021
Other
Subscription
0015000000ePOfRAAW
0015000000ePOfRAAW
R&D
0015000000ePOfR
SCTbio a.s.
238
12/1/2022
EU Sales User - R&D ENT
Zoltan Szarka
F. HOFFMANN-LA ROCHE AG
Renewal 2023: Roche Diagnostics SRT - 235 Licenses
5. Contracting
Q4-2023
99
303
12/1/2022
12/8/2021
Subscription
0015000000aQSXBAA4
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
R&D
0015000000aQSXB
0012J00002MJstk
Chugai Pharmaceutical Co.,Ltd.
239
12/1/2022
EU Sales User - R&D ENT
Zoltan Szarka
GlaxoSmithKline LLC
Renewal 2022: GSK Biopharma eTMF ELA
6. Awaiting P.O.
Q4-2023
99
295
12/1/2022
12/16/2021
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
240
12/1/2022
EU Sales User - R&D ENT
Zoltan Szarka
GlaxoSmithKline LLC
Renewal 2022: GSK Biopharma CTMS ELA
6. Awaiting P.O.
Q4-2023
99
295
12/1/2022
12/16/2021
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
241
12/1/2022
EU Sales User - R&D ENT
Maxime Orain
J&J Pharmaceuticals
Renewal 2023: Johnson & Johnson QualityDocs EU
4. Negotiation
Q4-2023
95
288
12/1/2022
12/23/2021
Sales
Subscription
0012J00002MJmrHQAT
0015000001RO8AFAA1
0015000001RO8AFAA1
0015000001RO8AFAA1
R&D
0012J00002MJmrH
0015000001RO8AF
Momenta Pharmaceuticals, Inc.
242
12/1/2022
EU Sales User - R&D SMB
Davide Pesenti
Recordati Rare Diseases Sarl
Renewal 2022 Dec: Renewal-Recordati Rare Diseases FR- eTMF 2021
4. Negotiation
Q4-2023
99
248
12/1/2022
2/1/2022
Sales
Subscription
0012J00002ZZKmtQAH
0015000000VSdDeAAL
0015000000VSdDeAAL
0015000000VSdDeAAL
R&D
0012J00002ZZKmt
0015000000VSdDe
EUSA Pharma
243
12/1/2022
US Sales User - Safety
Michael Heimann
SOTIO Biotech a.s.
Renewal 2022: SOTIO Biotech - QDocs ELA 200 / QMS ELA 200
4. Negotiation
Q4-2023
95
219
12/1/2022
3/2/2022
Sales
Subscription
0012J00002X2YJBQA3
0015000000ePOfRAAW
0015000000ePOfRAAW
0015000000ePOfRAAW
R&D
0012J00002X2YJB
0015000000ePOfR
SCTbio a.s.
244
12/1/2022
EU Sales User - R&D ENT
Zoltan Szarka
GlaxoSmithKline Biologicals SA
Renewal 2023: GSK Vaccines Vault Platform Reg Intel QRI 2021
5. Contracting
Q4-2023
99
203
12/1/2022
3/18/2022
Subscription
0015000000iVjitAAC
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
R&D
0015000000iVjit
0012J00002MJmoR
Tesaro, Inc.
245
12/1/2022
EU Sales User - R&D ENT
Julien Bechtel
UCB Biopharma SRL
Renewal Jan 2023: UCB Zogenix Legacy eTMF - $0 OF For migration
4. Negotiation
Q4-2023
95
35
12/1/2022
9/2/2022
Sales
Subscription
00150000018OaEYAA0
0012J00002MJ2bHQAT
0012J00002MJ2bHQAT
0012J00002MJ2bHQAT
R&D
00150000018OaEY
0012J00002bzOpx
Zogenix, Inc.
246
12/1/2022
US Sales User - R&D ENT
Lori Thorell
MSD Pharmaceuticals
Renewal 2023: Merck_Vault eTMF_
5. Contracting
Q4-2023
99
297
12/1/2022
12/14/2021
Sales
Subscription
0012J00002MJsusQAD
0012J00002LPcIzQAL
0012J00002LPcIzQAL
0012J00002LPcIzQAL
R&D
0012J00002MJsus
0012J00002LPcIz
Acceleron Pharma Inc.
247
12/1/2022
US Sales User - R&D SMB
Anthony Gotzis
J&J Pharmaceuticals
Renewal 2023: Johnson & Johnson QualityDocs - US split
4. Negotiation
Q4-2023
95
265
12/1/2022
1/15/2022
Sales
Subscription
0012J00002MJmrHQAT
0015000001RO8AFAA1
0015000001RO8AFAA1
0015000001RO8AFAA1
R&D
0012J00002MJmrH
0015000001RO8AF
Momenta Pharmaceuticals, Inc.
248
12/1/2022
US Sales User - Commercial ENT
Stefan Jahnecke
Elanco US Inc.
Renewal 2023: Elanco - CTMS + eTMF ELA
4. Negotiation
Q4-2023
95
310
12/1/2022
12/1/2021
Sales
Subscription
0015000000KQOA1AAP
0012J00002MKyheQAD
0012J00002MKyheQAD
0012J00002MKyheQAD
R&D
0015000000KQOA1
0012J00002MKyhe
Elanco Animal Health Inc.
249
12/1/2022
US Sales User - MedTech ENT
David Duffy
Boston Scientific Corporation
Renewal 2022: Boston Scientific - QMS
5. Contracting
Q4-2023
99
318
12/1/2022
11/23/2021
Sales
Subscription
0015000000LVRzoAAH
0012J00002MKhDCQA1
0012J00002MKhDCQA1
0012J00002MKhDCQA1
R&D
0015000000LVRzo
0012J00002MKhDC
Boston Scientific
250
12/2/2022
US Sales User - MedTech ENT
Ryan Lapinski
Abbott MedTech
Renewal 2022: Abbott Diabetes Care - NA - eTMF - 230ELA
5. Contracting
Q4-2023
99
309
12/2/2022
12/2/2021
Subscription
0012J00002ZERRwQAP
0012J00002MK4X8QAL
0012J00002MK4X8QAL
0012J00002MK4X8QAL
R&D
0012J00002ZERRw
0012J00002MK4X8
Abbott Laboratories, Inc.
251
12/2/2022
US Sales User - R&D ENT
Chris McShea
MSD Pharmaceuticals
Renewal 2022: Merck - QMS MRL
6. Awaiting P.O.
Q4-2023
99
309
12/2/2022
12/2/2021
Sales
Subscription
0012J00002MJsusQAD
0012J00002LPcIzQAL
0012J00002LPcIzQAL
0012J00002LPcIzQAL
R&D
0012J00002MJsus
0012J00002LPcIz
Acceleron Pharma Inc.
252
12/3/2022
EU Sales User - R&D ENT
Zoltan Szarka
Roche Diagnostics GmbH
Renewal 2022: Roche DIA - Veeva eConsent
2. Discovery
Q4-2023
20
308
12/3/2022
12/3/2021
Sales
Subscription
0015000000pJthCAAS
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
R&D
0015000000pJthC
0012J00002MJsuJ
Chugai Pharmaceutical Co.,Ltd.
253
12/7/2022
EU Sales User - R&D ENT
Mathieu De Sazilly
UCB Biopharma SRL
Renewal 2022: UCB - NextGen ECMS - SubmissionsArchive 20 users
4. Negotiation
Q4-2023
95
304
12/7/2022
12/7/2021
Sales
Subscription
00150000018OaEYAA0
0012J00002MJ2bHQAT
0012J00002MJ2bHQAT
0012J00002MJ2bHQAT
R&D
00150000018OaEY
0012J00002bzOpx
Zogenix, Inc.
254
12/7/2022
US Sales User - R&D ENT
Chris McShea
MSD Pharmaceuticals
Renewal 2022: Merck_RA HH_RIM Suite_Year 6 Renewal
5. Contracting
Q4-2023
99
304
12/7/2022
12/7/2021
Sales
Subscription
0012J00002MJsusQAD
0012J00002LPcIzQAL
0012J00002LPcIzQAL
0012J00002LPcIzQAL
R&D
0012J00002MJsus
0012J00002LPcIz
Acceleron Pharma Inc.
255
12/9/2022
EU Sales User - CDMS
Georg Schumm
Health Data Specialists S.A.
Renewal 2023: HeadsCRO - eTMF - 32 sites
4. Negotiation
Q4-2023
95
302
12/9/2022
12/9/2021
Sales
Subscription
0015000002IigC0AAJ
0015000002IigC0AAJ
R&D
0015000002IigC0
Health Data Specialists S.A.
256
12/10/2022
EU Sales User - R&D ENT
Zoltan Szarka
Roche Diagnostics GmbH
Renewal 2023: Roche Diagnostics eTMF ELA
5. Contracting
Q4-2023
99
330
12/10/2022
11/11/2021
Subscription
0015000000pJthCAAS
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
R&D
0015000000pJthC
0012J00002MJsuJ
Chugai Pharmaceutical Co.,Ltd.
257
12/10/2022
EU Sales User - R&D ENT
Zoltan Szarka
Roche Diabetes Care GmbH
Renewal 2023: Roche Diabetes Care CTMS, SSU, Payments
3. Proposal
Q4-2023
90
270
12/10/2022
1/10/2022
Subscription
00150000019uxEyAAI
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
R&D
00150000019uxEy
0012J00002MJstk
Chugai Pharmaceutical Co.,Ltd.
258
12/13/2022
EU Sales User - R&D ENT
Jürgen Grampp
F. Hoffmann-La Roche Ltd
Renewal 2023: Roche HTAg 1000 RO and 150 FU (EU&US)
6. Awaiting P.O.
Q4-2023
99
298
12/13/2022
12/13/2021
Subscription
0015000000VSdHgAAL
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
R&D
0015000000VSdHg
0012J00002MJstk
Chugai Pharmaceutical Co.,Ltd.
259
12/14/2022
US Sales User - MedTech ENT
Brendan Boere
Cerus Corporation
Renewal 2023: Cerus Corporation - QMS ELA400
4. Negotiation
Q4-2023
95
297
12/14/2022
12/14/2021
Sales
Subscription
0015000000Lq8BBAAZ
0015000000Lq8BBAAZ
R&D
0015000000Lq8BB
Cerus Corporation
260
12/14/2022
EU Sales User - R&D SMB
Rachel Rees
GlaxoSmithKline LLC
Renewal 2022: GSK Biopharma RIM ELA
4. Negotiation
Q4-2023
95
297
12/14/2022
12/14/2021
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
261
12/14/2022
EU Sales User - R&D SMB
Davide Pesenti
EUSA Pharma (UK) Ltd
Renewal 2022: EUSA Pharma (UK) Ltd - Vault QMS and QualityDocs - ELA 400
4. Negotiation
Q4-2023
95
297
12/14/2022
12/14/2021
Sales
Subscription
00150000018O5POAA0
0015000000VSdDeAAL
0015000000VSdDeAAL
0015000000VSdDeAAL
R&D
00150000018O5PO
0015000000VSdDe
EUSA Pharma
262
12/14/2022
US Sales User - R&D SMB
Teri Smith
Ernie Chin
American Regent, Inc.
Renewal 2023: American Regent _QDocs ELA
6. Awaiting P.O.
Q4-2023
99
297
12/14/2022
12/14/2021
Sales
Subscription
0015000000IO26vAAD
0012J00002MK4XEQA1
0012J00002MK4XEQA1
0012J00002MK4XEQA1
R&D
0015000000IO26v
0012J00002bzOnv
Daiichi Sankyo Co.,LTD
263
12/15/2022
US Sales User - R&D SMB
Nick Robison
Christopher Mundy
Endpoint Health Inc.
Renewal 2023: Endpoint Health - Vault eTMF/CTMS - 25 Site Count
3. Proposal
Q4-2023
95
296
12/15/2022
12/15/2021
Sales
Subscription
0012J00002ZExxBQAT
0012J00002ZExxBQAT
R&D
0012J00002ZExxB
Endpoint Health
264
12/15/2022
US Sales User - R&D SMB
Jonathan Benzimra
Adam De Oliveira
Luye Pharma (USA), Ltd
Renewal 2023: Luye - Vault Publishing
2. Discovery
Q4-2023
30
262
12/15/2022
1/18/2022
Subscription
0015000001MbT4CAAV
00150000025cbFjAAI
00150000025cbFjAAI
00150000025cbFjAAI
R&D
0015000001MbT4C
00150000025cbFj
Shandong Luye Pharmaceutical Co., Ltd
265
12/15/2022
US Sales User - R&D SMB
Jonathan Benzimra
Adam De Oliveira
Luye Pharma (USA), Ltd
Renewal 2023: Luye Pharma - US - Submissions
4. Negotiation
Q4-2023
95
262
12/15/2022
1/18/2022
Subscription
0015000001MbT4CAAV
00150000025cbFjAAI
00150000025cbFjAAI
00150000025cbFjAAI
R&D
0015000001MbT4C
00150000025cbFj
Shandong Luye Pharmaceutical Co., Ltd
266
12/15/2022
US Sales User - R&D SMB
Anthony Gotzis
J&J Pharmaceuticals
Renewal Jan 2023: Momenta RIM, QD, QMS, Training ELA200
4. Negotiation
Q4-2023
99
79
12/15/2022
7/20/2022
Subscription
0012J00002MJmrHQAT
0015000001RO8AFAA1
0015000001RO8AFAA1
0015000001RO8AFAA1
R&D
0012J00002MJmrH
0015000001RO8AF
Momenta Pharmaceuticals, Inc.
267
12/16/2022
US Sales User - R&D SMB
Tai Hornbeck
Jim Thai
Neurelis, Inc.
Renewal 2022: Neurelis - Vault QualityDocs and Vault Training - 200 ELA
4. Negotiation
Q4-2023
95
295
12/16/2022
12/16/2021
Subscription
0015000002IjF01AAF
0015000002IjF01AAF
R&D
0015000002IjF01
Neurelis, Inc.
268
12/16/2022
EU Sales User - R&D SMB
Davide Pesenti
Recordati S.P.A.
Renewal 2022: Recordati - Vault Development Cloud December
4. Negotiation
Q4-2023
95
254
12/16/2022
1/26/2022
Sales
Subscription
0015000000VSdDeAAL
0015000000VSdDeAAL
R&D
0015000000VSdDe
EUSA Pharma
269
12/16/2022
LatAm Manager - Sales
Antonio Faggioni
Cellera Famacêutica S/A
Renewal 2022: Cellera Brazil Submissions 8 Users + Base
4. Negotiation
Q4-2023
95
295
12/16/2022
12/16/2021
Sales
Subscription
0012J00002J2vsZQAR
0012J00002J2vsZQAR
R&D
0012J00002J2vsZ
Cellera Farma
270
12/17/2022
US Sales User - R&D SMB
Alexandra Furdyna
International AIDS Vaccine Initiative, Inc.
Renewal 2023: IAVI- eTMF 4 Archive Sites Mult-Year T002 Trial
Closed Won
Q4-2023
100
712
12/17/2022
1/4/2021
Renewal
00150000019DKfQAAW
00150000019DKfQAAW
eTMF
Vault
R&D
00150000019DKfQ
Aeras Global Tb Vaccine Foundation
271
12/17/2022
EU Sales User - R&D ENT
Katrien Mesotten
Sanofi Aventis Groupe
RENEWAL: 2023 Sanofi - eTMF ELA Yr 4 - US&EU
5. Contracting
Q4-2023
90
1247
12/17/2022
5/9/2019
Renewal
0015000000Kjce7AAB
0015000001TVjdfAAD
0015000001TVjdfAAD
0015000001TVjdfAAD
eTMF
Vault
R&D
0015000000Kjce7
0012J00002bz91p
Bioverativ, Inc.
272
12/17/2022
EU Sales User - R&D ENT
Zoltan Szarka
GlaxoSmithKline LLC
GSK Pharma Payments P3 Renewal
Closed Won
Q4-2023
100
871
12/17/2022
7/29/2020
Renewal
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
Payments
Vault
R&D
0015000000VSniv
0012J00002MJmoR
Tesaro, Inc.
273
12/17/2022
EU Sales User - R&D ENT
Katrien Mesotten
UCB Biopharma SRL
Renewal 2023: UCB - Trackwise replacement - QMS & QD ELA Y3
Closed Won
Q4-2023
100
754
12/17/2022
11/23/2020
Sales
Renewal
00150000018OaEYAA0